ReSUMe BOOK - Columbia Business School

Transcription

Healthcare Industry Association (HCIA)
ReSUMe BOOK
Columbia Healthcare
and Pharmaceutical
Management Program
Class of 2014
Class of 2015
Contents
2014 resumes
13 KAREN SOHN
QIANHUI (SALLY) SUN
KIRAN TADI
3 JASMINE AINETCHIAN
ARASH ASTANEHASL
LAUREN BARTLETT
14 Tony Tsai
Kaitlyn Wang
ELIZABETH WOL
4 JESSICA BASHAM
NAVEEN BAZAJ
ETHAN (ETAN) BENDHEIM
15 SAMUEL WOLLNER
AMANDA WOOD
TIFFANY BO XU
5 KEVIN CLARK
MELISSA FOO
YU GAO
16 IRIS MAO YE
DAVID ZHOU
RUOXUAN MICHAEL ZHU
6 Poorva Goyal
JIAYI HAO
REGINA HOUSTON
7 MARTHA HUGHES
JAKE JOLLY
TED KIRBY
8 JENNIFER LAM
MICHAEL LAU
STEPHANIE LEE
9 ASHLEY LEMAIRE
JOHN LEVIN
ALLISON LEVY
10 DEBBY MAN
CAITLIN MEVORACH
NICOLE NIU
11 JENNIFER NORTH
JOHN REYNOLDS
MARGOT SANGER-KATZ
12 FABIEN SCHUT
LIANA SHALELASHVILI
CLARE SKIRROW
2015 resumes
17NABILA AHMED
SEEMA BALANI
SCOTT E. BARTNICK
18SARAH BROWN
MATT CANTOR
MICAH CHILES
19SMRITA CHOUBEY
LEE COOPER
BRETT DERBY
20 GUILLEM GARCIA
MELISSA GAVIN
Michael Haddix
21 JING HE
JOSH HESSAN
BENJAMIN HINZ
22 JENNIFER HOLLENBERG
BENJAMIN HOLT
KATIE K. HUA
23 ALKA JHAVERI
JONGHO JOO
MICHAEL KELLNER
24 KRIS KEMENY
ANDREW KOCZO
SUSANNA LEAF
25 JAVIER LOPEZ-MOLINA
FARIDAH MANSOR
ELENA MAYER
26 ERIN JOY MUCKEY
WASIB MUHAMMAD
ROSALYN NGUYEN
27SCOTT NISBET
SCOTT NITZ
MARK PARSONSON
28 ARI PERL
RITU RAJAN
BRAD REISMAN
29 LIZA REYNOLDS
JENNIFER RHODES
STEVEN SACHS
30 CHRISTINA SARELAKOS
SAGAR SHAH
ZJ Shao
31GUNJAN SHESH
Robert Song
MONIKA SPIEWAK
32SABRINA STUCKA
ZAHRAH TAUFIQUE
KELLY THOMAS
33 ALEX TUROK
Nathan Walcker
ZHENZE (ANGELO) WANG
34 JENNY YANG
HCIA at Columbia Business School
The Healthcare Industry Association (HCIA) is committed to expanding opportunities
outside of the classroom for Columbia Business School students to learn about
the many segments of the healthcare industry. Working in close collaboration with
the Healthcare and Pharmaceutical Management Program, HCIA produces a variety
of activities throughout the year. It offers members the opportunity to increase
their knowledge of the healthcare industry, expand professional networks, learn about
diverse career paths in healthcare, and secure internships, full-time opportunities,
and in-semester projects.
The healthcare-related activities broaden students’ exposure to global healthcare
practice and complement the learning that occurs in the classroom. Students interact
regularly with leading industry practitioners, many of whom are alumni, through
experiential learning opportunities in the classroom. The following events are offered
throughout the year:
 Columbia
Business School Annual Healthcare Conference
 Healthcare
 Career
 “Day
Career “Supercharger”
Mentoring Breakfasts
in the Life” Events with select corporate partners
 Lunch
and Learn Networking Events
 Alumni
Networking Events
 Executive
Speakers
Peer-to-Peer
groups with Social Enterprise, Entrepreneurship,
Value-Investing, and others
HCIA members accept full-time and internship positions across the spectrum of
the healthcare industry. Many students are recruited into management development
rotation programs and functional positions (finance, marketing, business development,
strategic planning, etc.) at global healthcare enterprises and early-stage life sciences
and healthcare services companies. Students also obtain healthcare-focused positions
in consulting, investment banking, private equity, venture capital, and nonprofit
organizations.
2013 HCIA Resume Book
1
Healthcare and Pharmaceutical
Management Program
Columbia Business School’s Healthcare and Pharmaceutical Management (HPM)
Program provides students with a real-world understanding of the increasingly
complex healthcare environment. Through a multidisciplinary approach shaped by
innovative course offerings, complementary out-of-class activities, networking
opportunities with industry leaders, and one-on-one career planning/mentoring, the
Program offers a dynamic learning experience focused on the major issues
affecting the global healthcare ecosystem. The HPM Program emphasizes critical
thinking and encourages the development of new approaches to address the
strategic, economic, competitive, technological, and sociopolitical challenges facing
this important sector. Healthcare courses are offered as electives (no minimum
requirements) within the overall curriculum at Columbia Business School, enabling
students to tailor their coursework to their individual needs and career aspirations.
The HPM Program offers students:
 A
flexible, comprehensive, and pragmatic array of healthcare courses
 A career-focused approach to learning and professional development
 A powerful network of alumni and other healthcare business professionals
 A global perspective
 An entrepreneurial mindset
An attractive New York City location
 Access to the world-class Columbia healthcare community
The HPM Program was established in 2006 and is led by Professor Cliff Cramer, a
25+ year veteran of the healthcare, pharmaceutical and financial services sectors.
The Program was designed by seasoned industry executives who understand first-hand
the skills and industry insight necessary to be successful in this dynamic and highly
challenged global business sector.
Healthcare electives build on the MBA Program’s rigorous core-curriculum and are
designed and taught by a unique mix of experienced industry executives and prominent
CBS faculty. They cover each major healthcare sector (biopharmaceuticals, medical
devices and diagnostics, healthcare services and healthcare information technology) on
a global basis, from both industry and investor perspectives. Additionally, all functional
areas are covered: strategy, management, marketing, finance, business development,
M&A, risk management, operations and policy.
The Program helps students successfully pursue careers in pharmaceuticals, biotechnology, medical devices & diagnostics, healthcare services, healthcare information
technology (HCIT), management consulting, investment banking, equity research,
venture capital, private equity, and entrepreneurship.
Information on the HPM Program can be found at: www7.gsb.columbia.edu/healthcare/
2014 : Ainetchian – Bartlett
JASMINE AINETCHIAN
ARASH ASTANEHASL
LAUREN BARTLETT
jainetchian14@gsb.columbia.edu
aastanehasl14@gsb.columbia.edu
lbartlett14@gsb.columbia.edu
Management and Consulting
Strategy and Entrepreneurship
Management and Marketing
Johns Hopkins University
Baltimore, Maryland
BA, Public Health Studies, 2009
Georgia Institute of Technology
Atlanta, Georgia
BS, Biomedical Engineering, 2007
Lafayette College
Easton, Pennsylvania
BA, Economics & Business, French, 2008
BOSTON CONSULTING GROUP, Dallas, TX
Summer Consultant
2013
Assessed needs of $10b state agency’s
finance department in its adoption
of an Enterprise Resource Planning
(ERP) system.
BOOZ & COMPANY, New York, NY
Summer Associate, Health Practice
2013
Evaluated provider network, medical
management system, and informatics of
leading health insurance company.
PFIZER INC., New York, NY
Summer Marketing Associate
2013
Evaluated the performance of existing
digital initiatives and developed a strategy
and pilot program for an unbranded
campaign across multiple digital channels
for the Latin America Pain & CNS team.
Recommended executive-level financial
reporting strategy to reduce $100m+
annual budget overruns and enable datadriven project management.
IMPAQ INTERNATIONAL
Washington, DC
Research Analyst
2009 – 2012
Project Manager of two contracts for
the Centers for Medicare & Medicaid
Services ($2m+).
Evaluated Medicare bundled payment
demonstration (ACE) in 15 hospitals
over three years; analyzed estimated
$15m+ in savings for hospital sites,
identifying key learnings for feasibility of
future implementation nationwide.
Designed and analyzed survey of 2,500
Medicare beneficiaries; analyzed results
rating 60+ major US payers.
Acquired substantive knowledge of
Medicare fee-for-service, payment
bundling, Part C and D performance
measures, health and prescription
drug plan monitoring requirements.
Redesigned care management system
to generate $35m in annualized run-rate
savings.
INTEGRA LIFESCIENCES CORPORATION,
Washington, DC
Neurosurgery Sales Specialist
2010 – 2012
Directed sales of neurosurgery products
within $1.6m territory.
Completed strategic planning, relationship
building, and account targeting; improved
territory ranking from 96th to 3rd.
Shunt Sales Specialist
2008 – 2010
Developed and implemented strategies
for two regional managers and 20 local
representatives.
Pioneered new ways of managing accounts,
which led to restructured territories
within specialty sales and created tools
that helped grow business by 10%.
TRIAGE CONSULTING GROUP, Atlanta, GA
Associate
2007 – 2008
Specialized in hospital reimbursement and
revenue cycle, analyzing existing contracts
with insurance companies.
Recognized $500k+ of underpaid claims
through extensive research and developed
policy changes to prevent future losses.
Led a cross-emerging markets competitive
landscape analysis of the neuropathic
pain market, identified differentiation
opportunities, and developed recommendations for a market research program.
TESARO, INC., Waltham, MA
Business Development & Commercial Affairs
Intern
2011 – 2012
Generated valuation analyses and
gathered competitive intelligence for
prospective product in-license and
acquisition candidates.
Prepared SEC registration documents
and marketing materials utilized in the
company’s Initial Public Offering.
BANK OF AMERICA MERRILL LYNCH,
New York, NY
Healthcare Investment Banking
Associate (2011)
Senior Analyst (2010 – 2011)
Valued life science companies considering
financing and M&A opportunities using
discounted cash flow, comparable company
valuation, and transaction premium analyses.
Equity Capital Markets
Analyst
2008 – 2010
Executed over 50 equity and equity-linked
offerings across a variety of sectors.
3
2014 : Basham – Gao
JESSICA BASHAM
NAVEEN BAZAJ
ETHAN (ETAN) BENDHEIM
jbasham14@gsb.columbia.edu
nbazaj14@gsb.columbia.edu
ebendheim14@gsb.columbia.edu
Consulting
Management and Private Equity
Management and Finance
University of Virginia
Charlottesville, Virginia
BS, Commerce, 2008
University of California, Los Angeles
Los Angeles, California
BS, Biology, 2007
Yeshiva University
New York, New York
BA, History, 2008
BAIN & COMPANY, New York, NY
Summer Associate
2013
ALVINE PHARMACEUTICALS,
San Carlos, CA
Associate, Business Development
and Strategy
2011 – 2013
Secured a $70m option deal with Abbvie,
enabling the company to progress through
its next stage of product development.
PHIBRO ANIMAL HEALTH CORPORATION,
Teaneck, NJ
Manager, Financial Planning & Analysis,
PhibroChem Division
2009 – 2012
Oversaw internal financial controls, budgeting and analysis for $50m specialty
chemicals division.
Transformed a medical device company’s
go-to-market strategy for its European
operations, which was projected to
improve EBIT margin from -39% to 18%
through sales force modifications.
Conducted interviews with industry
executives to develop an actionable
implementation strategy.
WELLS FARGO BANK, Atlanta, GA
Financial Analyst, Commercial Bank
2010 – 2012
Managed a $250m portfolio of 20 clients
and supported senior relationship
managers with total portfolio of over
$4b in loan commitments.
Led client discussions to strategize on
new capital needs, potential acquisitions,
and performance updates.
WACHOVIA BANK, A WELLS FARGO
COMPANY, Charlotte, NC
Analyst, Fixed Income Derivatives
2008 – 2010
Provided US and Global interest rate
hedging solutions to large-cap clients
across industries.
Advised clients on optimizing their
debt mix through customized hedging
strategies, by analyzing current capital
structures, leverage, coverage ratios,
and business models.
Supported manufacturing and marketentry strategy development with senior
management team, advised on sources of
capital, and built relationships with over
25 venture capital firms and healthcare
companies.
RBC CAPITAL MARKETS, San Francisco, CA
Investment Banking Senior Analyst,
Healthcare
2010 – 2011
Lead analyst for over $500m in healthcare
sector transactions, including primary
advisor for $86m Endocyte IPO.
Managed all levels of transaction process
including: organization and information
gathering, valuation analysis, business due
diligence, developing client materials,
and presenting strategic alternatives to
management and board of directors.
LEHMAN BROTHERS / BARCLAYS
CAPITAL, Menlo Park, CA
Investment Banking Analyst, Technology
2008 – 2010
Lead analyst for over $3b in transactions
including $1.9b Cisco acquisition
and $745m Avago Technologies IPO.
Provided decision support to client
C-level executives for investor relations,
interactions with the SEC, and board
meetings.
4
10th Annual Columbia Business School Healthcare Conference
Presented analysis of results and forecasts,
which provided senior management insight
into business beyond the P&L.
Oversaw division’s supply chain management; spearheaded sourcing of new
antibiotic and yeast products for sale into
the US ethanol industry.
UBS INVESTMENT BANK, New York, NY
Analyst, Global Healthcare Group
2007 – 2009
Researched and executed M&A, equity
and debt pitches to companies across the
healthcare space.
Provided analysis used in internal bank
approval of IPO of Protalix Biotherapeutics;
assisted in preparing roadshow presentation
for $500m IPO.
Instituted and managed monthly speaker
series for first-year analysts in the
healthcare group.
ISRAEL DEFENSE FORCES, Israel
Infantryman
2005 – 2006
Graduated basic and advanced training with
the elite Haruv Brigade, which specialized
in urban combat/counter-terrorism in
and around the Palestinian-controlled city
of Nablus.
Managed and led three subordinates and
served as squad marksman.
KEVIN CLARK
MELISSA FOO
YU GAO
kclark14@gsb.columbia.edu
mfoo14@gsb.columbia.edu
ygao14@gsb.columbia.edu
Finance
Consulting and Entrepreneurship
Private Equity
University of Pennsylvania
Philadelphia, Pennsylvania
BSE, Bioengineering, 2008
Melbourne University Dental School
Melbourne, Australia
DDS, 2005
Purdue University
West Lafayette, Indiana
MS, Industrial Engineering, 2006
GOLDEN GATE CAPITAL, San Francisco, CA
Associate
2010 – 2012
Led due diligence, built financial forecasts
and buy-out models, and performed
market research on potential private equity
investments across multiple sectors.
MYDENTIST, Kuala Lumpur, Malaysia
Business Development and Marketing
2006 – 2012
Managed family-owned dental group with
subsidiaries in marketing and education;
devised and executed ideas for business
development.
Completed the $100m+ leveraged buyout
of EP Minerals and the $200m+ IPO of
US Silica.
Worked closely with executive management teams at portfolio companies to
assess operating performance, monitor
financials, and evaluate potential add on
acquisition opportunities.
BLOXR, Salt Lake City, UT
Consultant
2010, 2012
Performed addressable market sizing
analysis for healthcare startup, identifying
50m+ medical procedures with product
applications.
Developed investor presentation materials
and met with VC firms prior to successfully
obtaining $2m of initial funding.
BAIN & COMPANY, Boston, MA
Associate Consultant
2008 – 2010
Worked on three to six person teams,
focusing on strategy and implementation to
drive value for clients in private equity,
pharmaceuticals, financial services,
technology, and defense.
Collaborated with senior client management on projects in adjacency growth
strategy, product line profitability
and portfolio optimization, organizational
structure design, customer support
optimization, and distribution channel
effectiveness.
Developed CSR program by leveraging
strategic alliances between high net worth
clients and Operation Smile International.
MINISTRY OF HEALTH, Kuala Lumpur,
Malaysia
Dentist, Oral & Maxillofacial Surgery
2006 – 2009
Offered highly-coveted resident position
in department based on performance
during internship.
Implemented public policy program,
developed framework for research in
maxillofacial trauma, authored and
presented research at collaborative
seminars in Malaysia and China.
Shanghai Jiao Tong University
Shanghai, China
BE, Electrical Engineering, 2005
ZS ASSOCIATES, New York, NY
Consultant (2011 – 2013)
Associate Consultant (2009 – 2011)
Associate (2007 – 2009)
Managed 40+ projects for over 20 major
biopharmaceutical and medical device
companies in US, UK, Germany, France,
Spain, and China.
Led a post-merger sales force integration
work stream for a $60b pharmaceutical
company and optimized the structure and
the size of its joint sales force in the US.
Developed a customer integration strategy
and implementation plan for a leading
medical device company during its $20b
acquisition.
Conducted the valuation of a €4.5b
Belgian pharmaceutical company on behalf
of a company during its bidding process.
Forecasted product launch and licensing
opportunities in 47 emerging markets
for a Japanese company and designed
organizational structure for its Korea
expansion.
Developed a market entry and exit strategy
for a portfolio of over 600 non-protected
molecules; identified 30 high-potential
launch and divestiture opportunities in 23
emerging markets.
Designed an agent-based simulation
model, which led to a white paper and the
creation of a company practice area.
5
2014 : Goyal – Kirby
Poorva Goyal
JIAYI HAO
REGINA HOUSTON
pgoyal14@gsb.columbia.edu
jhao14@gsb.columbia.edu
rhouston14@gsb.columbia.edu
Consulting and Management
Georgia Institute of Technology
Atlanta, Georgia
PhD, Biochemistry, 2008
Dartmouth College
Hanover, New Hampshire
AB, Economics, 2008
BA, Philosophy, Politics, and Economics (PPE),
2008
Indian Institute of Technology
Mumbai, India
BS, Chemistry, 2003
CELGENE, Summit, NJ
Summer Associate, Corporate Strategy
2013
Prepared growth strategy for 19 emerging
countries (including BRICMT) outlining
strategic, operational, and financial
implications of the investment.
Conducted interviews of corporate and
in-country leaders, analyzed third-party
research, and presented findings to
senior-level executives.
QUINTILES, Hawthorne, NY
Summer Consultant
2012
Advised large pharmaceutical company
on market access strategy with focus on
personalized medicine.
Constructed growth projections for
CRO industry through analysis of financial
and industry trends.
LIPOID, Newark, NJ and Ludwigshafen,
Germany
Regional Sales Manager (2011)
Product Manager (2008 – 2010)
Led sales and business development
for pharmaceutical, consumer products,
and consumer healthcare companies
in North America.
MCKINSEY & COMPANY, Summit, NJ
Summer Associate
2013
Prioritized post-merger divestiture
opportunities for a large national hospital
system, yielding projected EBITDA
margin improvement of 2% and improved
overall portfolio alignment.
Identified strategic acquisitions to
strengthen system footprint in key markets
or expand into new high-growth markets.
IMS CONSULTING GROUP,
New York, NY and Shanghai, China
Senior Consultant
2008 – 2012
Led large, global teams to execute launch
pricing and strategy, competitor risk
mitigation, and market access optimization
projects for top pharmaceutical companies.
Deepened firm expertise on key market
access hurdles for Western drugs in China
and implications of ongoing healthcare
reforms for key clients during seven-month
secondment.
Developed thought leadership material
on evolving role of companion diagnostics
in oncology and alternative value drivers
for new oncologics.
Managed customer accounts and doubled
revenues to $2m.
Conceptualized targeted marketing, and
booth redesign at a major tradeshow
resulting in 20% new clients.
Liaised with clients’ and my firm’s R&D,
marketing and regulatory functions to
design client-specific solutions.
6
BOOZ & COMPANY, New York, NY
Summer Associate, Health Practice
2013
Defined go-to-market strategy around
health insurance plan attributes, distribution
channels, and customer experience for
large health insurance company entering
new market.
Conducted comprehensive analysis of
above and below-the-line benefits for
comparable plans across top competitors
for health insurance client.
ACHIEVE BEYOND, New York, NY
Manager
2010 – 2012
Managed staff of seven employees across
two departments within privately owned
company with $40m in annual revenue.
Streamlined processes of both departments
resulting in 50% decrease in overhead
without productivity loss.
Developed and implemented clearly
defined procedures, roles and responsibilities to increase accountability and build
a cohesive team.
Devised and implemented new bonus
structure for staff across both departments
to successfully incentivize company goals.
Collected and analyzed data on a monthly
basis regarding localized demand for services
to adjust marketing focus and recruiting
needs for new clinicians.
MARTHA HUGHES
JAKE JOLLY
TED KIRBY
mhughes14@gsb.columbia.edu
jjolly14@gsb.columbia.edu
tkirby14@gsb.columbia.edu
Strategy and Entrepreneurship
Villanova University
Villanova, Pennsylvania
BA, Economics and Pre-Med, 2009
Cornell University
Ithaca, New York
BS, Computer Science, 2008
University of North Carolina
Chapel Hill, North Carolina
BS, Business Administration, 2008
L.E.K. CONSULTING, New York, NY
Summer Consultant
2013
Created detailed staffing model and
ROI analysis for a leading health insurance
company; outlined the strategic,
operational, and financial impacts of
changes to their medical management
function in the advent of healthcare
reform.
GOOGLE, Mountain View, CA
Media Services Graduate Intern
2013
Developed an operations strategy
playbook, instituted standard
commercialization processes, and
defined organizational responsibilities
for launching new products.
DELOITTE CONSULTING, New York, NY
Summer Associate
2013
Developed growth strategy for a $39b
health insurance company within the
Medicare Advantage market.
Established market segmentation,
pricing strategy, and revenue forecast for
a Phase II obesity drug.
QUEST DIAGNOSTICS INC., Madison, NJ
Financial Analyst
2009 – 2012
Conducted analysis, developed budgets,
and created ongoing forecasts for
largest line of business ($5.9b revenue,
$4.8b expenses).
Selected by CFO to co-lead task force
to drive employee engagement for 150+
corporate finance employees.
Managed total company weekly volume
reporting to senior management
for 25+ business units around the world.
Managed $200m+ capital expenditure
budget and forecast; conducted review of
all capital expenditure endeavors over
$1m and presented potential projects to
finance leadership.
Reengineered company-wide capital
expenditure policy and process, trained
500+ employees around the country on
new policy, and reinstated the senior
management capital committee.
Operationalized project management
software for use by the ad products
commercialization team, created a library
of standardized project management
tools/templates/checklists, and built an
internal team site.
Senior Consultant
2012
Advised pediatric hospital CFO and
team in development and execution of
high-level business strategy, revenue cycle
operational transformation, and tactical
billing systems implementation.
Consultant
2010 – 2012
Led project team in the implementation
of an enterprise-wide electronic
medical record including business process
optimization and organizational
restructuring.
Analyst
2008 – 2010
Served as testing project manager for the
six-month testing cycle of an enterprise
electronic medical record at a multi-facility
hospital network.
Supervised the activation of an enterprise
electronic medical record at two 200+
bed hospitals, overseeing the accuracy and
reliability of patient information.
Built market share projection model to
understand competitive landscape and
identify most attractive new markets
for growth.
QUINTILES, Durham, NC
Senior Analyst
2011 – 2012
Led competitive intelligence, set-up
infrastructure, identified competitor
strategies and top customers, and
created sales responses.
Developed performance-based sales
strategy; determined 10 performance
metrics beat industry by up to 60%,
resulting in Quintiles trials having an 11%
higher rate of success.
Consultant
2010 – 2011
Created ROI model for patient recruitment
advertising; demonstrated 4x ROI and two
month enrollment time reduction.
Created new quality index for Quintiles
Board of Directors, linking audit findings to
patient data.
Managed all global CRA visit reporting for
C-Suite, comprising ~$100m in revenue per
month.
2009 – 2010
Led process improvement project for
$35b pharmaceutical company resulting in
5% (~$1m) savings per trial.
Developed new operational and enrollment
strategy for $120m Neurology trial.
7
2014 : Lam – Levy
JENNIFER LAM
MICHAEL LAU
STEPHANIE LEE
jlam14@gsb.columbia.edu
mlau14@gsb.columbia.edu
stlee14@gsb.columbia.edu
Strategy and Consulting
Western University
London, Ontario, Canada
BA, Business Administration, 2009
University of California, San Diego
La Jolla, California
ME, Bioengineering, 2008
Brown University
Providence, Rhode Island
BA, Classics, 2008
BAYER BUSINESS CONSULTING,
Wayne, NJ
Summer Associate
2013
Designed a strategic framework to assist
healthcare brand managers with the
selection of digital channels in order to
optimize marketing resources and integrate
initiatives with existing brand plans.
Led a workshop with global sales and
marketing leaders to review digital opportunities following a current state assessment and strategic alignment activities with
a team spanning Europe, Latin America
and Asia-Pacific.
Analyzed an emerging international
competitor for the consumer care leadership team to identify potential threats
posed to Bayer’s current OTC product
portfolio.
DELOITTE CONSULTING, Toronto, Ontario
Consultant
2009 – 2012
Delivered a variety of strategic projects to
financial services institutions.
Identified improvements to critical customer
interactions across an international
insurance client’s three lines of business,
and developed a strategic three-year
roadmap.
Helped a large Canadian bank develop a
strategic response to regulatory change
by conducting a global industry scan and
a detailed scenario analysis.
WOMANACT, Toronto, Ontario
Non-Profit Board Member
2010 – 2012
Provided oversight to help deliver coordinated care to abused women.
8
University of California, San Diego
La Jolla, California
BS, Bioengineering, 2007
DELOITTE CONSULTING, San Francisco, CA
Summer Associate
2013
Core team member on a project for a
leading medical diagnostics company to
research and conceptualize a next
generation product offering using voice of
customer, house of quality, and quality
function development tools.
MEDTRONIC, Carlsbad, CA
Senior Project Engineer
2010 – 2012
Led cross-functional teams to determine
and address root cause of product
failures/complaints and implement design/
process improvements to Class II
medical device product with successful FDA
510(k) approval.
Research and Development Engineer
2009 – 2010
Led and managed cross-functional,
international project team to design, and
implement product improvements with
a $500k budget.
Designed and prototyped innovative
cardiac mapping catheter currently used
in limited human clinical testing with
patents pending.
ABLATION FRONTIERS, Carlsbad, CA
Preclinical Engineer
2008 – 2009
Published research as first author in a
peer-reviewed journal.
Created presentations and briefings for
marketing use and FDA Advisory
Committee Review for PMA device
approval for use in the US.
CELGENE, Summit, NJ
Summer Associate
2013
Worked in Global Pricing and Market
Access group to develop pricing strategies
for Revlimid.
Led pricing project on novel combination
therapy pricing strategy in both US and
global markets.
Developed health economics and outcomes
(HEOR) gap analysis.
KYRUUS, Boston, MA
Pre-MBA Intern
2012
Formulated growth strategies within industry
and provider spaces for Kyruus, an early
stage healthcare tech startup in the provider
space.
Provided analysis and best practices
for academic medical centers and other
providers using big data technologies.
IMS CONSULTING GROUP, Parsippany, NJ
Consultant
2010 – 2012
Created pricing models for a range of
large-cap pharmaceutical, biotech, and
medical device companies with government
contracts.
Wrote policies and pricing methodologies
based on CMS guidelines and internal
strategy.
Advised large pharmaceutical companies on
payer contracts for post-merger integration.
ASHLEY LEMAIRE
JOHN LEVIN
ALLISON LEVY
alemaire14@gsb.columbia.edu
jlevin14@gsb.columbia.edu
alevy14@gsb.columbia.edu
Finance and Entrepreneurship
Consulting and Strategy
BA, Health and Societies, 2009
Yale University
New Haven, Connecticut
BA, Economics, 2004
Brandeis University
Waltham, Massachusetts
BA, International and Global Studies, 2009
MEMORIAL SLOAN-KETTERING CANCER
CENTER, New York, NY
Performance Improvement Specialist I
2011 – Present
Perform multi-disciplinary root cause
analysis for hospital service groups,
prompting rapid results projects.
Manage completion of monthly audits
for adherence to government standards
and publication on the hospital wide
dashboard.
Research Study Assistant I–II
2009 – 2011
Facilitated Phase I to III clinical research
studies for investigators and pharmaceutical
companies, including scheduling, tracking,
data collection, and analysis.
Partnered with radiology service to
present findings regarding biopsy sampling
to Department of Medicine for corrective
action purposes.
Mentored new hires and delegated
trial responsibilities following employee
transitions according to contracted
standards and deadlines.
CHILDREN’S HOSPITAL OF PHILADELPHIA,
Philadelphia, PA
Finance Intern to the President
2009
Reviewed excel inputs and reported
trends to finance manager.
Attended senior executive board meetings
and interviewed top leaders for professional
insights.
Baltimore, Maryland
Select online courses, non-degree program
HEALTHIFYME.COM, Bangalore, India
Intern
2013
Presented to VCs and business development partners for startup healthcare firm
in India.
FEDERAL RESERVE BANK OF NEW YORK,
New York, NY
Markets Group Intern
2013
Briefed senior policy makers on leveraged
finance and municipal bond markets.
INTERNATIONAL FINANCE
CORPORATION, New Delhi, India
Volunteer Research Intern
2012
Evaluated investment climate for medical
education across countries to recommend
improvements to Indian regulations.
PUBLIC RESOURCES ADVISORY GROUP,
New York, NY
Vice President (2011 – 2012)
Assistant Vice President (2009 – 2010)
Associate (2006 – 2008)
Analyst (2005)
Structured and priced dozens of
municipal debt transactions totaling
several billion dollars.
Healthcare transactions include a $58m
bond issuance and credit research for a
California hospital.
NEWYORK-PRESBYTERIAN HOSPITAL,
New York, NY
Operations Intern
2013
Interviewed and collaborated with revenue
cycle and operations analysts, surgeons,
and other hospital leaders to analyze
impact of surgical volume and reimbursement shifts.
Analyzed surgical data pertaining to case
volume and presented data standardization,
patient acquisition, and profitability
strategies to senior executive leadership.
BIPARTISAN POLICY CENTER,
Washington, DC
Health Policy Analyst
2011 – 2012
Developed and evaluated healthcare
reform policies, focusing on Medicaid,
Medicare, healthcare workforce, cost
containment, and insurance reform.
Managed task forces and large stakeholder
collaborations with senior political leaders,
industry executives, and policy analysts to
produce research papers, policy recommendations, and high-profile conferences.
Conceptualized and implemented the BPC
Health Project political strategy.
NEW AMERICA FOUNDATION,
Washington, DC
Program Associate
2009 – 2011
Performed health reform policy analysis;
authored and edited policy briefs, white
papers, blog posts, and presentations.
9
2014 : Man – Sanger-Katz
DEBBY MAN
CAITLIN MEVORACH
NICOLE NIU
dman14@gsb.columbia.edu
cmevorach14@gsb.columbia.edu
qniu14@gsb.columbia.edu
Management and Technology
Operations and Finance
University of Maryland, College Park
College Park, Maryland
BS, Information Systems and International
Business, 2007
Bowdoin College
Brunswick, Maine
BA, Mathematics, 2009
Indiana University
Bloomington, Indiana
PhD, Biochemistry, 2009
DELOITTE CONSULTING, McLean, VA
Senior Consultant
2007 – 2012
Delivered and executed eight technology
and strategy consulting projects following
the standard project lifecycle.
Designed and implemented four custom
case management systems for multiple
business units within a federal institution,
minimizing manual data entry, and reducing
paper consumption by at least 50%.
Implemented a public-facing website for
online submission of applications and
supplemental documents, increasing a
federal institution’s efficiency in processing
monthly license applications by 100%.
Defined the architecture design and
implementation of a customer relationship
management plan for a national nonprofit organization.
Identified areas of opportunity to increase
efficiency in contract implementation by
conducting and analyzing time and motion
studies of a major telecommunications
company’s business processes.
Designed the telesales business strategy
and operations for the launch of a
two-tiered Wi-Fi product for a major
telecommunications company.
10
GOLDMAN SACHS, New York, NY
Summer Associate, Healthcare
2013
Advised in buy-side transaction; performed
leveraged buyout, accretion-dilution, and
contingent value rights analyses.
Created valuation and strategic alternatives
materials outlining options to reposition a
stagnant growth business.
DELOITTE CONSULTING, Boston, MA
Consultant
2009 – 2011
Developed and built Decision Support
system for $3b yearly revenue hospital system;
outputs are utilized to create a more
flexible and granular cost accounting system
to identify system-wide efficiencies
resulting in 20%+ savings.
Created and implemented cost effective
plan at a Health Plan for meeting US health
reform IT and clinical coding mandates
by gathering processes covering ~90% of
business areas.
Coordinated transition in ownership of
a +$3b revenue global pharmaceutical
including manufacturing, supply chain, and
delivery.
AMERICAN WELL SYSTEMS, Boston, MA
Intern, Product Management
2011
Responsible for end-to-end product
management of design, requirements,
technical documents, wireframes,
PRDs and a customer facing website.
Xiamen University
Xiamen, China
BS, Life Sciences, 2001
GENSCRIPT, Piscataway, NJ
Regional Sales Manager
2011 – 2013
Led a team of three people, responsible
for $20m US market revenue generation.
Analyzed the buying process of industrial,
academic, and governmental customers;
designed offering to fulfill different needs
of each segment.
Sales Account Manager
2009 – 2011
Cultivated partnership with various business
units, distributors, and local associations
through incentive programs and frequent
communication; achieved 28% sales growth
in assigned territory.
Provided first-hand market intelligence to
marketing department, enabling the
formulation of competitor-specific strategies.
INDIANA UNIVERSITY, Bloomington, IN
Graduate Student Researcher
2003 – 2009
Conducted structural and biochemical
studies of proteins involved in Huntington’s
Disease; research resulted in award of
$1.2m NIH grant.
Presented research findings in international
conference and initiated collaboration
with patient-run foundation; attracted seed
funding to perform pre-clinical research.
JENNIFER NORTH
JOHN REYNOLDS
MARGOT SANGER-KATZ
jnorth14@gsb.columbia.edu
jreynolds14@gsb.columbia.edu
msangerkatz14@gsb.columbia.edu
Business Development and Private Equity
Finance and Investment Management
Journalism
Stanford University
Stanford, California
BA, Economics, 2007
Trinity College
Hartford, Connecticut
BA, American Studies, 2009
Columbia University
New York, New York
MS, Journalisn, 2003
CELGENE, Summit, NJ
Business Development Summer Intern
2013
Developed online portal and dashboard
for CEO to track financial and strategic
progress of past acquisitions and
investments.
JENNISON ASSOCIATES, New York, NY
Intern, Research-Equity Department
2013
Compiled findings on coverage universe
and assisted in various research projects
for healthcare investment team.
Worked with clinical, commercial, legal
and accounting teams to structure
R&D collaborations, investments and
acquisitions with early stage biotechnology
companies to develop innovative drug
products and strengthen Celgene’s
oncology franchise.
LEE EQUITY PARTNERS, New York, NY
Private Equity Associate
2009 – 2011
Evaluated growth equity investments in
the healthcare services and HCIT sectors
through rigorous analysis of industry,
financial and competitive trends.
Constructed complex, bottoms-up operating
forecast models to assess valuation and
financing structures for investments and
exit strategies.
Developed fund investment strategy and
identified top targets for Urgent Care
and Ambulatory Surgery Center sectors.
GOLDMAN SACHS, New York, NY
Investment Banking Analyst, Healthcare
2007 – 2009
Analyzed M&A, IPO, leveraged buy-out,
anti-raid, and corporate restructuring
transactions for payer, distribution,
laboratory, biopharmaceutical, and HCIT
clients.
Built integrated operating and financing
models to perform valuation through
discounted cash flow, sum-of-the-parts,
accretion-dilution, LBO, comparable
company, and precedent transaction
analyses.
THINKEQUITY, New York, NY
Investment Banking Associate
2010 – 2012
Analyzed healthcare companies
to identify new business, determine
valuations, and assess strategic
alternatives.
Assisted senior bankers and client
management teams in execution of a
variety of capital-raising and advisory
transactions.
Built comprehensive financial models
and valued companies using a variety of
techniques, including public market
comparables, precedent transactions,
discounted cash-flow, and merger analysis.
Generated confidential information
memoranda, investor and board presentations, and financial analyses for clients.
Led Analyst training program covering
accounting, modeling, valuation analyses,
databases, and marketing materials.
BCMS CORPORATE, New York, NY
Analyst, Mergers and Acquisitions
2009 – 2010
Produced in-depth business plans
while working closely with client senior
management.
Yale University
New Haven, Connecticut
BA, English, 2002
NATIONAL JOURNAL, Washington, DC
Healthcare Correspondent
2011 – 2013
Covered healthcare for the DC politics
and policy magazine; wrote analyses and
long-form narrative pieces for the weekly
print magazine and breaking news and
investigative stories for the Web.
Reported on federal health policy and the
business of healthcare; recent subjects
included implementation of the Affordable
Care Act, hospital consolidation, and the
health spending slowdown.
Appeared as a healthcare expert on
national television and radio stations,
including PBS, MSNBC, NPR, and C-SPAN.
YALE ALUMNI MAGAZINE, New Haven, CT
Senior Staff Editor
2010 – 2011
Edited science and medicine coverage
for an editorially independent alumni
magazine.
CONCORD MONITOR, Concord, NH
Health Care Reporter
2005 – 2010
Wrote breaking news, analysis, and feature
stories on healthcare; beat included health
policy, hospitals, public health, and medical
research.
Lead point of contact during document
production stage of M&A process.
2013 HCIA Resume Book 11
2014 : Schut – Tadi
FABIEN SCHUT
LIANA SHALELASHVILI
CLARE SKIRROW
fschut14@gsb.columbia.edu
lshalelashvili14@gsb.columbia.edu
cskirrow14@gsb.columbia.edu
Finance
Marketing and Business Development
HEC Lausanne
Lausanne, Switzerland
MS, Financial Engineering, 2010
I.M. Sechenov First Moscow State
Medical University
Moscow, Russia
MS, Pharmacy and Pharmaceutical Sciences,
2008
University of Cambridge
Cambridge, United Kingdom
MA, Natural Sciences (Biochemistry), 2010
MCKINSEY & COMPANY,
Geneva, Switzerland
Business Analyst
2010 – 2012
Developed an innovative sales force
sizing model for a pharmaceutical company,
which is being turned into a McKinsey
capability platform; facilitated negotiations
between two European business unit
heads regarding the new sales force
structure, leading to savings of over $20m
by pooling resources while increasing
growth prospects.
Developed a robust campaign management
process for an agro-chemical company;
led the conception of supporting tools to
set campaign standards and enable the
coordination of campaigns across two
newly integrated business units; worked
jointly with marketing, sales and sales
support client teams sitting in Europe, Asia
and America.
LYXOR ASSET MANAGEMENT,
Paris, France
Intern
2010
Led a research project on dynamic risk
management for the Quantitative Research
team; results subsequently appeared on a
white paper published by the firm.
BAYER HEALTHCARE
Whippany, NJ
MBA Marketing Intern
2013
Assessed market opportunity for Hemophilia
drug, Kogenate FS, in the Hispanic market;
developed marketing strategy, which was
implemented into 2014 business plan.
Managed a cross-functional team of brand
managers, field sales force, and agency
counterparts to develop a regional execution
plan for Hispanic sales representatives.
ALPHA CAPITAL HOLDINGS, INC,
New York, NY
Venture Associate
2010 – 2012
Evaluated and assessed biomedical industry
opportunities and business plans in terms
of market size, marketability, mechanism
of delivery, uniqueness of technology, and
process as well as the competitive and
strategic landscape.
Collaborated with company principles
on structuring deals and key investment
decisions.
CSC PHARMACEUTICALS,
Moscow, Russia
Assistant Manager, Regulatory Affairs
2009 – 2010
Built strategies with cross-functional teams
from sales, ma2rketing, and research on
labeling and packaging for maximization of
sales and regulatory compliance.
Led projects to obtain significantly accelerated marketing authorizations for three
foreign drugs with the Regulatory
Authorities of the Russian Federation.
12
University of Cambridge
BA, Natural Sciences (Biochemistry), 2006
GENENTECH INC., San Francisco, CA
Actemra Market Planning MBA Intern
2013
Analyzed market research and claims data
to identify key business trends impacting
brand sales growth.
Managed team in the design and
implementation of qualitative market
research study.
Collaborated with internal teams to
synthesize market research output and
provide strategic recommendations to
brand team.
Supported team in preparation of
long-term brand forecasts approved by
executive leadership.
MARSH LTD., London, United Kingdom
Assistant Vice President, Structured Credit
and Political Risks
2010 – 2012
Developed and managed key client
relationships, advising on political risk
and structured credit insurance
requirements.
Led teams in multiple geographies,
coordinating broking strategies to negotiate
best solutions for clients.
KAREN SOHN
QIANHUI (SALLY) SUN
KIRAN TADI
ksohn14@gsb.columbia.edu
qsun14@gsb.columbia.edu
ktadi14@gsb.columbia.edu
Marketing and Consulting
Management and Strategy
University of California, Santa Barbara
Santa Barbara, California
PhD, Materials Engineering, 2008
City University of Hong Kong
Hong Kong
BBA, Accountancy and Finance, 2006
New York Medical College
Valhalla, New York
PhD, 2006
BSE, Materials Science and Engineering, 2003
MATCHSTICK, Boonton, NJ
Associate
2012 – Present
Led design and execution of studies to
understand user preferences for currently
marketed drug-device combination products
and apply insights to breakthrough
concept-stage drug delivery technologies.
Combined scientific and marketing
background to contribute to clinical study
development to characterize product
use risk.
BECTON DICKINSON, Franklin Lakes, NJ
Senior Engineer, Medical Surgical Systems
2008 – 2011
Led customer centricity strategy development aimed at increasing customer
focus across the business and presented
implementation plan to business
leadership team.
Interfaced with clinicians and hospital
management globally to identify areas of
unmet needs for new products.
Proposed strategy for business growth
into adjacent spaces to business leadership
based on discussions with key opinion
leaders as part of cross-functional innovation team.
DEUTSCHE BANK, Hong Kong
Senior Associate, Corporate Finance
2010 – 2012
Led and managed execution process of
IPO deals and follow-on offerings on HKEx
and NASDAQ as well as bond issuance.
Advised on M&A and capital markets
transactions, including trade sale, spin-off,
dual listing, and transfer of listing.
Acted as primary communication channel
with HKEx for IPOs.
MACQUARIE CAPITAL, Hong Kong
Executive
2008 – 2010
Conducted industry analysis and prepared
pitch books to cover real estate companies
in Asia.
Performed financial analysis and asset
management on Macquarie’s principal
investment.
Advised on project financing, reverse
takeover, privatization, share repurchase,
and partial offer transactions.
Conducted deal structuring and return
analysis on wholesale fund and trust for
commercial properties.
ABN AMRO BANK, Hong Kong and London,
United Kingdom
Analyst
2006 – 2008
Rotated through Equity Capital Markets,
M&A, Debt Capital Markets, and Direct
Investment.
Jawaharlal Institute of Medical Education
and Research
Pondicherry, India
MBBS, 2001
VIRTUA MEDICAL GROUP, Mt. Holly, NJ
Hospitalist Physician
2009 – Present
Coordinate multispecialty physician team
as an attending physician in Internal
Medicine.
Presented a poster at the annual Society
for Hospital Medicine meeting focused on
the Care Coordination model.
Represented Virtua Health at the Clinical
Advisory Board National Meeting Series
held in Washington, DC.
Evaluate prospective physicians for
employment at Virtua Health as a member
of the Credentials Committee.
Represented the hospitalist team for
inpatient clinical research projects with
the clinical trials office.
SOUND SHORE MEDICAL CENTER,
New Rochelle, NY
Internship and Residency in Internal Medicine
2006 – 2009
Board Certified in Internal Medicine.
Authored abstracts and journal articles
in clinical journals.
Performed extensive DCF and M&A
modeling, comparable and transaction
analysis, and credit rating analysis.
Analyzed potential investment opportunities
through industry and fundamental analysis.
2014 : Tsai – Xu
Tony Tsai
Kaitlyn Wang
ELIZABETH WOL
ttsai14@gsb.columbia.edu
kwang14@gsb.columbia.edu
ewol14@gsb.columbia.edu
Management and Entrepreneurship
Strategy and Management
School of Medicine
MD, 2001
Arizona State University
Tempe, Arizona
MS, Bioengineering, 2006
Dartmouth College
BA, Government, 2007
Baltimore, Maryland
BS, Biophysics, 1996
ALLERGAN INC., Santa Barbara, CA
Senior Biomaterials Professional
2011 – 2012
Managed relationships and improved
collaborations within three research teams
for fat-grafting project for aesthetics
and breast implant applications, meeting
2011 milestone two months early.
BETH ISRAEL MEDICAL CENTER,
New York, NY
Attending Anesthesiologist
2008 – Present
Involved in patient care.
ST. LUKE’S-ROOSEVELT HOSPITAL
Attending Anesthesiologist
2006 – 2007
Involved with patient care and medical
education of residents.
Operating room coordinator – in charge of
planning for anesthesia coverage of all
operating room cases.
Regional Anesthesiology Fellow
2005
Fellow in regional anesthesia, involved with
patient care, clinical outcomes research,
and medical education of residents.
Anesthesiology Resident
2002 – 2005
Resident in anesthesiology department,
involved in patient care and clinical
outcomes research.
CARILION ROANOKE MEMORIAL
HOSPITALS, Roanoke, VA
General Surgery Intern
2001 – 2002
Intern in general surgery department,
involved in patient care.
14
Carried out research on novel plastic surgery
products and led technology transfer to
2013 product development portfolio.
Constructed global development plan
for a novel soft tissue reconstruction
product with a $500m market together
with global marketing, regulatory, and
manufacturing teams.
MEDTRONIC INC., Santa Rosa, CA
Scientist
2007 – 2009
Conducted research with physicians to
identify unmet clinical needs and coordinated with R&D engineers to initiate projects.
Built and led five person team to develop
a novel drug delivery system for peripheral
vascular disease treatment with a limited
budget and strengthened R&D product
pipeline.
ILYPSA INC. (acquired by AMGEN),
Santa Clara, CA
Associate Scientist
2006 – 2007
Developed and improved a novel
nanoparticle drug for treatment of chronic
kidney disease (CKD) in a team of 12
members, leading to $420m acquisition by
Amgen in 2007.
MCKINSEY & COMPANY, Summit, NJ
Summer Associate
2013
Analyzed preliminary performance of
healthcare providers under recently
reformed payment model.
Developed strategy for client to engage
low-performing providers to promote
deeper understanding of model and
encourage performance improvement.
NEWTON-WELLESLEY HOSPITAL,
Newton, MA
Project Manager, Online Giving
2010 – 2011
Led six person team that designed and
implemented donation/registration
website for walk-a-thon (serving 1,400
walkers and raising $270k).
Analyzed data collected via website and
projected event size and revenue.
Development Associate
2009 – 2011
Implemented department-wide protocols
for tracking active work streams and
projected income and led training for
development staff.
Conducted quantitative analysis of projected
income data and presented reports to
senior administrators.
Developed proposals for strategic fundraising initiatives through collaboration
with physicians and administrators.
CHATHAM PARTNERS,
Waltham, MA
Senior Research Analyst (2008 – 2009)
Research Analyst (2007)
Conducted quantitative and qualitative
research related to the client life cycle (new
business wins/losses, client satisfaction/
loyalty, drivers of departed clients).
Managed several day-to-day client relationships and supervised research analysts in
data collection and analysis.
SAMUEL WOLLNER
AMANDA WOOD
TIFFANY BO XU
swollner14@gsb.columbia.edu
awood14@gsb.columbia.edu
bxu14@gsb.columbia.edu
Consulting and Social Enterprise
Strategy
Harvard College
Cambridge, Massachusetts
AB, Biological Anthropology, 2008
Vassar College
Poughkeepsie, New York
BA, Psychology, 2009
Baylor University
Waco, Texas
MS, Biomedical Engineering, 2008
NEWYORK-PRESBYTERIAN HOSPITAL,
New York, NY
MBA Intern
2013
Led redesign process of data dashboard
for senior management.
SOCIAL FINANCE, INC., San Francisco, CA
Capital Markets Summer Associate
2013
Supported CFO in evaluation and
negotiation of $50m capital raise from
hedge fund.
Collaborated with hospital leadership in
operations, nursing, and IT to build
consensus on key organizational metrics
and user interface enhancements.
Constructed financial models and
conducted sensitivity analyses with focus
on balancing impact of cost of debt
and potential for future equity dilution.
Performed analyses of patient volume
trends in the New York metropolitan area.
Created business plans for two new
loan products by analyzing competitive
landscape, determining optimal pricing
and terms, and planning roll out across
all functional areas.
Provided physician leadership with insights
on market potential for a new endocrine
surgery service line.
UNIVERSITY OF PITTSBURGH MEDICAL
CENTER, Baltimore, MD
Analyst
2010 – 2012
Managed Department of Defense contracted
project to identify innovative diagnostic
technologies and strategies that could
improve global infectious disease outbreak
surveillance.
Engaged major commercial laboratory
companies to initiate a possible publicprivate partnership to improve diagnostic
capacity following a radiological event to
identify those in need of treatment.
BETH ISRAEL DEACONESS MEDICAL
CENTER, Boston, MA
Research Assistant
2008 – 2010
Designed research initiative for a major
supermarket chain to assess the efficacy
of an in-store labeling program to help
customers make healthier choices.
Led weight loss outcomes analysis for a
clinical weight loss company’s pilot project
to provide services in a major retail
pharmacy chain.
BRIGHAM AND WOMEN’S HOSPITAL,
Boston, MA
Development Associate
2011 – 2012
Led fundraising initiatives targeting
strategic partners in support of $65m
annual goal; exceeded goal by 5%.
Collaborated with senior management to
budget, plan, and fundraise for $32m
project.
BNY MELLON, Boston, MA
Investment Specialist
2009 – 2011
Coordinated with two Senior Portfolio
Managers to manage $300m portfolio of
150 clients.
Managed relationship with external
multi-family office with $750m portfolio of
100 clients.
Executed asset transfers, currency
transactions, and performance analyses
for over 400 investment accounts.
Donghua University
Shanghai, China
BE, Electrical Engineering, 2006
BA, English, 2006
NORTHERN LIGHT VENTURE CAPITAL,
Beijing, China
MBA Intern, Healthcare Investment
2013
Made investment recommendations about
medical device industry by studying key
industry value drivers and deal history, and
interviewing startups and incubators.
BECTON DICKINSON, San Jose, CA
MBA Intern, Strategic Portfolio Management
2013
Formulated a value-creation focused
methodology to guide the further improvement of BDB’s portfolio management
process, based on a thorough understanding
of the business and findings through industry
best practice research.
Developed a set of forward looking,
value-based metrics to facilitate the leadership in making portfolio decisions
about optimizing core business portfolio
and making innovation project selection.
MONSANTO, Oxnard, CA
Engineer II / Project Management
2010 – 2012
Led a four-person team to manage
research and manufacturing process
improvement projects from design,
development to validation.
MERCK & CO., Rahway, NJ
Analyst
2008 – 2010
Developed analytical tools to assist preclinical compound research with disease
areas covering diabetes, cardiovascular,
and osteoporosis.
2014 : Ye – Zhu
IRIS MAO YE
DAVID ZHOU
RUOXUAN MICHAEL ZHU
mye14@gsb.columbia.edu
tzhou14@gsb.columbia.edu
rzhu14@gsb.columbia.edu
Consulting and Marketing
Management and Finance
Consulting
University of Macau
Macau, China
MS, Medical Administration, 2008
Peking University
Beijing, China
BS, Biotechnology, 2008
University of Chicago
Chicago, Illinois
BA, Economics, 2009
BS, Mathematics and Computer Science,
2009
Shanghai Jiao Tong University
Shanghai, China
MS, Pharmaceuticals, 2008
JOHNSON & JOHNSON,
Beijing, China
Intern, Strategic Marketing – CNS
2013
Led positioning analysis for the launch of
Sustenna and developed portfolio strategy
for the CNS market.
ASTRAZENECA, Shanghai, China
Associate Brand Manager
2010 – 2011
Achieved record-breaking 334% growth in
2011, promoting Crestor from a minimal
market player to second largest in China.
Led cross-functional team for market
analysis and strategic planning in
Percutaneous Coronary Intervention
market, which made up 46% of Crestor’s
total market share.
Senior Medical Science Liaison
2009 – 2010
Established a five-year strategy and action
plan of medical communication for
Crestor, which gained approval from the
senior management team.
Co-managed 17 junior medical science
liaisons, including hiring, mentoring, and
training.
Medical Information Associate
2008 – 2009
Led project team of seven to promote a
medical information on-line platform
among internal and external customers,
increasing inquiries by 92%.
Received 2009 AstraZeneca Aurora
Award.
16
Hong Kong
Summer Associate
2013
CITIC PRIVATE EQUITY TEAM,
Beijing, China
Summer Investment Manager
2013
BAYER HEALTHCARE
PHARMACEUTICALS, Beijing, China
Manager, Strategy and Business Development
2011 – 2012
Expanded Bayer’s medicine portfolio and
business coverage to bolster growth in
Greater China; made product acquisition
deals and M&A deals of China’s pharmaceutical companies, with objective to boost
over $200m revenue inorganically.
Conducted due diligence on product
potential, manufacturing sites, and financials
to screen target companies and product
lines; core member of JV deal negotiations.
IBM GLOBAL BUSINESS SERVICES,
Beijing, China
Senior Consultant
2010 – 2011
Advised on customer segmentation,
product planning and sales management
for $1b medical device producer.
ROLAND BERGER STRATEGY
CONSULTANTS, Beijing, China and
Munich, Germany
Consultant
2008 – 2010
Advised on reorganizational initiatives of
a Fortune 500 pharmaceutical company
with European consultants in Munich.
BRISTOL-MYERS SQUIBB, Plainsboro, NJ
MBA Intern, Market Access
2013
Researched the effects of the Affordable
Care Act on providers and how those
changes will impact pharmaceutical
companies.
Identified key quality metrics that will
impact Bristol-Myers Squibb’s various
therapeutic areas.
ZS ASSOCIATES, Evanston, IL
2011 – 2012
Led sales force optimization projects for
three top 50 pharmaceutical companies.
Forecasted sales and analyzed market
conditions for several treatment
areas, such as diabetes, cardiovascular,
and neuroscience.
Optimized operations at a top 50 pharmaceutical by identifying critical pain points
due to interdepartmental inefficiencies and
advising management on how to resolve or
alleviate those issues.
Oversaw the creation of next-generation
internal management and project planning
tools.
Trained new associates in technical skills
such as Excel, Access, VBA, and SAS.
Associate
2009 – 2011
Analyzed prescription behavior of physicians
based on the marketing activity they
received from pharmaceutical companies.
Created customized data solutions for
client field teams to quickly capture and
analyze data while at customer sites.
2015 : Ahmed – Bartnick
NABILA AHMED
SEEMA BALANI
SCOTT E. BARTNICK
nahmed15@gsb.columbia.edu
sbalani15@gsb.columbia.edu
sbartnick15@gsb.columbia.edu
Consulting and Social Enterprise
Finance and Consulting
Chicago, Illinois
BA, Public Policy Studies, 2009
Emory University
Atlanta, Georgia
BA, Economics and Spanish, 2008
University of Florida
Gainesville, Florida
MS, Decision and Information Sciences, 2008
NERA ECONOMIC CONSULTING,
Washington, DC
Analyst
2009 – 2013
Applied rigorous economic analysis in
Intellectual Property litigation to determine
damages in connection with infringement
and breach-of-contract claims involving
patents, trademarks, copyrights, and
trade secrets; addressed such issues as
the commercial success of a patent in the
pharmaceuticals space.
DELOITTE CONSULTING, Atlanta, GA
Consultant
2008 – 2013
Developed and executed strategic recommendations for payer clients to implement
healthcare reform regulations.
Utilized market-based pricing techniques,
benchmarking studies, and rigorous valuation
methodologies to design intercompany
pricing policies for global biopharmaceutical
and automotive companies that met the
arms length requirements imposed by
national tax authorities.
NATIONAL OPINION RESEARCH CENTER,
Bethesda, MD
Research Assistant, International Projects
2009
Supported implementation of survey
instruments for an impact evaluation study
in Maseru, Lesotho.
Conducted analysis of market and community health data to create optimal patient
service model for the merger of three
non-profit health providers.
Led assessment and redesign of ER
patient experience across a seven-hospital
provider system.
Created analytical model to determine
geographic footprint and operating model
changes needed to achieve $10m savings
for a client’s international business.
DRISHTEE FOUNDATION, Bihar, India
Rural Development Volunteer
2011 – 2012
Led women’s empowerment pilot project
to develop impoverished female entrepreneurs and provide affordable access to
women’s health products in villages.
Executed community education and
marketing campaigns to identify income
advancement opportunities for women.
Built rural retail training curriculum and
provided ongoing coaching to three rural
entrepreneurs.
University of Florida
Gainesville, Florida
BS, Accounting, 2006
RED OAK GROWTH PARTNERS,
New York, NY
Private Equity Intern
2013
Evaluate investment opportunities in the
software, internet/media, and healthcare
IT spaces via in-depth analysis of financial
performance, market dynamics, and
customer trends.
Construct detailed financial and operational
models to determine valuation and optimal
transaction structure.
MEDNAX INC., Sunrise, FL
Senior M&A Analyst
2012 – 2013
Lead analyst on deal team for six physician
group practice acquisitions totaling
approximately $290m in spend.
Led or supported all aspects of the
transaction process, including sourcing,
valuation modeling, assessment of practice
management/operations, analysis of
transaction structures, and conducting/
coordinating financial and legal due
diligence.
DELOITTE & TOUCHE, Miami, FL
Audit Senior
2008 – 2012
Designed, planned and coordinated audit
testing across multiple large public and
non-public clients in the aerospace,
defense, healthcare, energy, and retail
industries.
Prepared purchase accounting analysis
and reviewed intangible asset valuations
for client’s strategic acquisitions (five
acquisitions during a two year period).
Ranked first in class of 15 professionals for
2010 and 2011.
2015 : Brown – Derby
SARAH BROWN
MATT CANTOR
MICAH CHILES
sbrown15@gsb.columbia.edu
mcantor15@gsb.columbia.edu
mchiles15@gsb.columbia.edu
Venture Capital and Entrepreneurship
Consulting and Finance
Princeton University
Princeton, New Jersey
AB, English, 2009
Cornell University
Ithaca, New York
BS, Policy Analysis and Management, 2009
AVALERE HEALTH, Washington, DC
Manager
2010 – 2013
Advised life science companies on strategic
decision-making around key market and
policy trends, with a specific focus on the
commercial implications of healthcare
reform.
FITCAUSE, New York, NY
Co-Founder, COO
2013
Led business development activities leading
to revenue generating contracts within the
first six months of operations.
Accepted into the Nike/Techstars three
month incubator program, hosted at Nike
headquarters.
JOHNSON & JOHNSON VISION CARE, INC.,
Jacksonville, FL
ODLean Senior Consultant
2011 – 2013
Led 19 onsite transformations as engagement manager, which resulted in 10-30%
productivity and revenue gains, and
50-75% reduction in patient wait time.
Served as Client Manager for three
pharmaceutical companies; identified and
initiated projects to address commercial
priorities, managed all project teams,
responsible for 600% increase in a client’s
sales to Avalere in one year.
Elected as youngest member of firm
leadership and business development
team.
LEERINK SWANN, Boston, MA
Analyst
2009 – 2010
Worked in teams to present data-driven
recommendations to pharmaceutical
clients, based on interviews and market
research.
Created a database of every hospital
in the US, stratifying the market by
comparative advantages for neurologic
care, to be used by large pharmaceutical
company to better engage hospitals
around its brain trauma product.
Consultant
2009 – 2013
Supported healthcare venture capital
clients with target identification and due
diligence efforts, leading to $30m of
invested capital.
Supported portfolio management activities
including: educating executive teams on
the impact of healthcare reform, identifying potential partnership opportunities,
and developing growth strategies and exit
options.
Conducted market analysis and due
diligence activities validating the $25m
sales pipeline of an acquisition target in
the drug safety space.
Executed a sourcing assessment, helping
to identify $30m in savings for the
maintenance and repair spend category
for a global beverage distributor.
Constructed financial model for major
pharmaceutical company to forecast sales
and revenue of its flagship product about
to lose patent in European markets, and
identified opportunities to extend product
lifecycle and increase ROI.
18
Identified quality gap and designed a
standard project format for all consultants;
variation between consultants reduced
to 10% and consultant days required per
project reduced by 30%.
Recognized for outstanding engagement
outcome by trade publication editorial,
Optometric Management, ODLean’s first
editorial.
Senior Territory Business Manager, Sales
Leadership Development Program
2008 – 2011
Managed relationships with over 250
physicians and increased sales of Vistakon
products 6-12% each year; excelled in four
product launches and consistently ranked
in the top 10-25% (220 reps) during tenure.
Trained and coached 27 TBMs during
tenure as Field Sales Trainer and Primary
Sales School Trainer.
Inducted and trained as youngest member
of J&J Management Development Program
(MDP).
SMRITA CHOUBEY
LEE COOPER
BRETT DERBY
schoubey15@gsb.columbia.edu
lcooper15@gsb.columbia.edu
bderby15@gsb.columbia.edu
Finance and Strategy
Private Equity and Entrepreneurship
Finance and Management
Chicago, Illinois
BA, Economics, 2010
Columbia Law School
New York, New York
JD, 2015
University of Southern California
J.P. MORGAN, New York, NY
Investment Banking Analyst,
Public Finance Healthcare
2010 – 2013
Structured and executed tax-exempt and
taxable debt financings for the nation’s
largest not-for-profit hospitals and health
systems.
Created comprehensive operating models
to assess debt capacity, evaluate various
financial products and enhance clients’
overall capital structures.
Advised clients adapting to a changing
competitive landscape through detailed
analysis of opportunities for expansion and
targets for acquisition.
Investment Banking Summer Analyst,
Public Finance Central Region Group
2009
Structured various municipal debt offering
transactions for state and local governments
in the Midwest.
Monitored clients’ capital structures to
identify potential restructuring opportunities.
GOLDMAN SACHS, Chicago, IL
Investment Banking Summer Analyst,
Consumer Retail Group
2008
Worked with senior management of leading
retail conglomerates on structuring
acquisitions, potential leveraged buyouts
and convertible debt offering transactions.
Dartmouth College
AB, Arts Religion, 2009
ALLAZO HEALTH, New York, NY
Business Development
2013
Built investor and client pitch decks, and
worked directly with Health IT startup
CEO to lead other business development
and operational projects for this Blueprint
Health accelerator graduate.
ARTISAN HEALTHCARE CONSULTING,
Waltham, MA
Associate (2010 – 2011)
Prepared analysis and wrote ‘Personalized
Medicine’ and ‘Rare Disease Launch’
strategic plans for a major US oncology
franchise.
Supported biotech business development
teams with market research, investor
decks, and deal terms calculators across
several major therapeutic classes.
Managed workflows for quantitative analysis
of health industry data sources to support
drug launches and sales efforts.
EDWARDS LIFESCIENCES, Irvine, CA
Senior Analyst, Sales Strategy & Operations
2010 – 2013
Directed the assessment of over 1,500
hospitals to construct successful
US commercialization plan for SAPIEN
Transcatheter Heart Valves.
Activated and grew 250 accounts working
directly with customers, senior management, and sales representatives.
Led Sales Management through quarterly
deep-dives into regional performance and
generation of strategic initiatives, hiring,
and capital allocation plans.
DAVITA, El Segundo, CA
Redwoods Business Analyst, Revenue
Operations
2010 – 2011
Led the implementation of process
improvements resulting in additional $20m
of annual income through reduction in
bad-debt write-offs.
Presented inefficiencies in existing claims
filing methodology to leadership based on
due diligence and analysis.
Optimized operations with introduction of
best demonstrated practices across 900+
employees.
Created holistic Excel models on clients’
projected profitability with sensitized
results for high-level client presentations.
Developed financial modeling acumen and
gained familiarity with various M&A and
leveraged buyout models.
2015 : Garcia – Hinz
GUILLEM GARCIA
MELISSA GAVIN
Michael Haddix
ggarcia15@gsb.columbia.edu
mgavin15@gsb.columbia.edu
mhaddix15@gsb.columbia.edu
Consulting and Finance
Marketing and Strategy
Finance
ESADE Business School
Barcelona, Spain
MS, Management, 2010
Emory University
Atlanta, Georgia
BBA, Business Administration and
Mathematics, 2008
Siena College
Loudonville, New York
BA, Psychology and Pre-Medicine, 2007
ESADE Business School
Barcelona, Spain
BS, Management, 2010
BAIN & COMPANY, Madrid, Spain
Senior Associate Consultant
2011 – 2013
Prepared commercial due diligence reports
focused on determining key industry revenue and cost trends and drivers, assessed
potential risks, and established a Bain view
on the overall attractiveness
of the opportunity.
Supported an international private equity
fund in revisiting customer, service,
and profitability strategies of a portfolio
company.
Coordinated project management office
for a communication campaign for 35
Spanish NGOs.
A.T. KEARNEY, Madrid, Spain
Senior Business Analyst
2010 – 2011
Defined optimal commercial footprint for
a leading pharmaceutical company.
Contributed to commercial due diligence
report focused on determining key revenue
and cost trends and drivers and potential
risks in the medical transportation industry.
Co-designed revamped sales channel strategy and sales force effectiveness by refocusing commercial effort and adapting
sales footprint for an international tobacco
company.
20
MONITOR GROUP, Boston, MA
(acquired by Deloitte Consulting)
Senior Consultant
2010 – 2013
Advised major pharmaceutical and health
insurance companies across executive
level marketing and corporate strategy
challenges.
Managed one to four consultants per project,
crafted project deliverables, managed
client relationships, and presented findings.
Led 2011-2012 undergraduate recruiting
efforts, including the design and execution
of the 2012 summer internship program.
INSIGHT SOURCING GROUP, Atlanta, GA
Analyst
2008 – 2010
Utilized strategic sourcing techniques
to reduce clients’ bottom line spend.
Consolidated supplier financial bids,
analyzed results, created summaries,
and savings strategies.
CIGNA, Philadelphia, PA
Actuarial Intern
2007
Conducted an incidence study to
review pricing for short-term disability
insurance products.
BOSTON SCIENTIFIC, New York, NY
Account Manager
2011 – 2013
Contributed to product development with
the launch of first of its kind medical
device to help treat long term asthmatics.
Managed international training forums to
help educate physicians on innovative
techniques.
Directed four member teams including
physicians and nurses before, during, and
after clinical procedures in order to
increase efficiency and reduce negative
outcomes.
COVIDIEN, Albany, NY
Energy Expert
2008 – 2011
Developed new technique for a clinical
procedure which led to revenue growth
company wide.
Achieved growth by over 20% in revenue
year over year by partnering with over
50 physician clients and over 20 hospital
CEOs.
JING HE
JOSH HESSAN
BENJAMIN HINZ
jhe15@gsb.columbia.edu
jhessan15@gsb.columbia.edu
bhinz15@gsb.columbia.edu
Consulting
Washington University in St. Louis
St. Louis, Missouri
MS, Chemistry, 2010
Massachusetts Institute of Technology
BS, Economics, 2008
University of Colorado at Boulder
Boulder, Colorado
MONITOR GROUP, New York, NY
(acquired by Deloitte Consulting)
Manager (2011 – 2013)
Senior Consultant (2009 – 2011)
Designed and developed global and
localized marketing processes for
a biotechnology firm; trained over 50%
of the global marketing employees
on the new process as well as 20% of
the medical and market access staff.
U.S. MARINE CORPS, San Diego, CA
Officer
F/A-18 Hornet Instructor Pilot
2000 – 2013
Trained, mentored, and evaluated staff
instructor aircrew and students in latest
Marine Corps combat aviation tactics,
generating 335 combat ready aircrew.
Peking University
Beijing, China
BS, Chemistry, 2008
LEERINK SWANN, San Francisco, CA
Summer Associate
2013
Evaluated potential value of three pipeline
drugs to create inputs for future demand
model for a biotech IPO.
Interviewed industrial experts and
synthesized results to forecast future
clinical trial results.
GLIDING EAGLES, San Jose, CA
Summer Intern
2013
Assessed and presented the Chinese
demand of US medicines and medical
devices to CEO.
Created strategies on logistics for
US healthcare manufacturers to reach
Chinese market.
REGENERON PHARMACEUTICALS,
Tarrytown, NY
Research Associate II
2010 – 2013
Led qualification method development for
a product generating revenues of $840m
in 2012 (60% of revenues).
Coordinated the organizational change
efforts of a healthcare group purchasing
organization, with anticipated results
of 5-10% growth in operating margin.
Facilitated project management office
for a pharmaceutical company as it
successfully launched its first blood
glucose monitor within the diabetes
therapeutic area.
Led team in evaluating the attractiveness for Japanese pharmaceutical client
to expand into medical imaging space;
developed market entry strategy
that aligned the organization’s core
competencies.
Developed a holistic pre-launch brand
strategy for an innovative Phase III
antiplatelet medication.
Devised and executed an accelerated
training plan that minimized student time
to train by 12% during a five-month training
operation, enabling squadron to meet
production goals for first time in seven
years.
Reshaped underperforming instructor
training program by establishing concrete
training objectives and structured scheduling process, reduced time to train new
instructors by 50%.
Led the maintenance training program
for 130 aircraft technicians responsible for
maintaining 12 fighter aircraft totaling
$480m.
Led preparation efforts for quality
assurance inspection by Commander
Naval Air forces, maintenance training
program received highest possible grade
and ranked 1st out of 40 maintenance
programs.
Managed cross-function projects as departmental liaison with Finance, Commercial
and R&D for new drug applications to FDA.
Reformed HR policies affecting 1300
service members, increasing the speed
personnel were separated from the
organization by 60%.
Executed analytical methodology to move
five drug candidates in oncology from early
development to clinical trials.
Top 5% of graduates, named Naval Air
Training Distinguished Graduate.
Negotiated bids with vendors, achieved
savings in equipment and supplies of
over 15%.
Communicated with business partners to
update and clarify key information based
on data analysis.
2015 : Hollenberg – Kellner
JENNIFER HOLLENBERG
BENJAMIN HOLT
KATIE K. HUA
jhollenberg15@gsb.columbia.edu
bholt15@gsb.columbia.edu
khua15@gsb.columbia.edu
Marketing and Consulting
Finance and Management
Strategy and Marketing
Cornell University
Ithaca, New York
BS, Applied Economics and Management,
2008
Cambridge University
BA, History, 2006
BSE, Chemical Engineering and
Environmental Studies, 2009
MCCANN REGAN CAMPBELL WARD,
New York, NY
Senior Account Executive
2011 – 2013
Developed US marketing materials
for healthcare professionals and patients
for multi-indication product (Novartis
Oncology’s Sandostatin® LAR Depot).
Launched the first iPad detail app for
both indications, ensuring that content and
functionality enhanced field force and
customer engagement.
Led multi-channel communication initiative
to raise disease awareness and increase
early diagnosis.
PWC, London, United Kingdom and
Philadelphia, PA
Manager, Capital Markets and
Accounting Advisory
2013
Provided technical accounting diligence to
clients in healthcare and utility sectors.
Reviewed carve-out investment prospectus
for $200m acquisition of interventional
medicine product by UK specialist healthcare company.
Manager, Assurance
2012 – 2013
Coordinated global audit of Fortune 500
pharmaceutical company.
Awarded additional business, increasing
scope of account from $1.8m to $4.5m.
Oversaw execution of over 50 PWC teams
worldwide, addressed issues raised with
senior client management.
New Business Analyst
2010
Assessed prospective new clients by
researching pipelines of major pharmaceutical companies.
Analyzed accounting for select corporate
transactions, including a $3b biopharmaceutical acquisition and intellectual property
restructuring.
Coordinated all aspects of new business
pitch leading to eight new accounts.
STEBA BIOTECH, New York, NY
Clinical Trials Assistant
2008 – 2009
Collected outcome data and managed
materials, working with research coordinators across 10 European and US clinical
sites.
Organized international conference on
localized prostate cancer in Paris with 100+
attendees.
22
Senior Associate
2009 – 2012
Managed nine junior staff on audit of $13b
US pharmaceutical subsidiary.
Assessed client’s forecasting of grossto-net revenue deductions, including the
impact of healthcare reform.
Associate
2006 – 2009
Served a range of healthcare clients,
ranging in size from a medical device
start-up undergoing Series C financing to
large pharmaceutical.
ACCENTURE, New York, NY
Consultant
2009 – 2013
Collaborated with director-level client in
implementing a global web analytic tool for
pharmaceutical multi-channel marketing.
Created playbook to facilitate global
standardization of digital asset tagging and
interaction data analysis tools.
Advised a global pharmaceutical company
on post-merger rebate operations and
contract integration strategy.
Directed testing efforts across five teams
with onshore and offshore teams of 10
for a pharmaceutical managed markets
systems integration project.
Designed over 20 business reports intended
to provide clients with better understanding
of rebates payment and chargebacks
EDI (Electronic Data Interchange) data.
Established new contract design and payment processing flows in order to implement
a global pharmaceutical client’s largest
rebate contract.
Promoted from Analyst to Consultant
in 2011 due to top performance (ranked
within top 5% of peer group).
ALKA JHAVERI
JONGHO JOO
MICHAEL KELLNER
ajhaveri15@gsb.columbia.edu
jjoo15@gsb.columbia.edu
mkellner14@gsb.columbia.edu
Marketing and Management
Finance and Private Equity
Operations and Entrepreneurship
University of Maryland, College Park
College Park, Maryland
BS, Finance, 2009
BS, Operations Management, 2009
Seoul National University
Seoul, Korea
MS, Biomedical Engineering, 2008
Columbia University College
of Physicians & Surgeons
New York, New York
MD, 2015
Consultant
2009 – 2013
Led current state assessment of a Fortune
20 Pharmacy Benefit Manager’s (PBM)
pre-implementation audit process; identified
comprehensive process improvement plan
to boost operational efficiencies and to
increase customer service level; new process
resulted in faster queue times, a 30%
decrease in errors, and 100% of external
Benefits Consulting firms adopting the
standardized process.
Developed business cases for a mid-tier
PBM to evaluate the qualification and
inclusion of targeted infrastructure programs
and investments; analyzed impact to client
migration plan and proposed recommendations that totaled savings of over $92m
over five years.
Designed and tested 100+ customer
relationship capabilities that enabled
Fortune 100 Health Insurers to effectively
identify potential leads and manage
marketing campaigns; facilitated workshops
and interviews with senior marketing
managers to identify gaps in current process
and to conduct analysis of functional
requirements.
Conducted assessment of provider’s
ambulatory processes and resources to
develop a resource capacity model.
Seoul National University
Seoul, Korea
BSE, Electrical Engineering, 2006
ALTOS VENTURES, Menlo Park, CA
Intern
2013 – Present
Conducted market analysis to aid
partners in assessing the Korean market
and the startup’s investment attractiveness
in the area.
Conducted financial analysis for portfolio
companies to evaluate quarterly performance and set strategic agenda for growth.
BOOZ & COMPANY, Seoul, Korea
Consultant
2011 – 2013
Conducted industry analysis for a group of
companies including healthcare, media,
and steal producers for strategy formulation.
Analyzed business assessment for companies to evaluate performance and set
new initiatives.
SAMSUNG MEDISON, Seoul, Korea
Associate Research Engineer
2008 – 2011
Developed new ultrasound technologies
to detect arterial disease, participating in
the entire process from algorithm design
to clinical trials.
Northeastern University
Boston, Massachusetts
BS, Biology, 2009
COLUMBIA NEUROSURGERY,
New York, NY
Clinical Coordinator
2009 – 2010
During the year between college and
medical school, initiated multicenter Phase
II clinical trial giving orphan drug to stroke
patients to improve recovery (n=30).
Navigated among neurosurgeons, nurses,
pharmacists, and other hospital staff as
well as pharmaceutical company, FDA, IRB,
and DSMB oversight committee.
WESTWOOD PAINTING, Westwood, MA
Owner
2004 – 2005
Started and operated a full service
residential exterior painting company for
two years following high school.
Managed multiple painting crews, advertising, marketing, logistics, budgeting, negotiations, sales, and day-to-day operations of
the business.
Conducted industry, technology, and
competitor analysis to set new business
areas for growth.
2015 : Kemeny – Mayer
KRIS KEMENY
ANDREW KOCZO
SUSANNA LEAF
kkemeny15@gsb.columbia.edu
akoczo15@gsb.columbia.edu
sleaf15@gsb.columbia.edu
Finance and Entrepreneurship
Finance
BA, Economics, International Relations, and
Political Science, 2008
Swarthmore College
Swarthmore, Pennsylvania
BA, Economics and Psychology, 2007
BA, Economics and Hispanic Studies, 2008
ERNST & YOUNG CAPITAL ADVISORS,
New York, NY
Associate, Healthcare M&A
2011 – 2013
Covered healthcare companies on
buy-side and sell-side M&A transactions,
including businesses operating in outpatient rehabilitation, dental, healthcare
IT, payer, and drug distribution industries.
BERKELEY RESEARCH GROUP,
Washington, DC
Managing Consultant (2013)
Consultant (2012)
Senior Associate (2010 – 2011)
Assisted counsel for a major pharmaceutical
manufacturer under investigation by the
federal government for allegedly lowering
drug rebate payments to Medicaid agencies;
analysis resulted in an 80% reduction in
damages.
THE ADVISORY BOARD COMPANY,
Washington, DC
Associate Principal, Corporate Strategy
and New Product Development
2011 – 2013
Managed product design, build, and launch
of industry’s first data analytics technology,
which enables hospitals to accountable
care payment models.
Directed team of 20 engineers in building
technology, recruited five early hospital
development partners, led training of eight
person sales team, and produced marketing
pitch and materials.
Served as subject matter expert on bundled
payment, shared savings, and accountable
care payment models in 80+ sales visits
with hospital executives.
GOLDMAN SACHS, Los Angeles, CA
Senior Analyst, Investment Management
2008 – 2011
Defined strategic asset allocations; managed
portfolio construction, analysis, and
trading across broad array of asset classes;
researched and monitored performance
of $9.8b of assets under management.
Led new client acquisition initiatives resulting
in $2b of potential assets under team
management; developed system that identified, prioritized, and tracked new business
opportunities; model became a best
practice for US division.
Prepared strategic pitches for private
and public clients ranging from start-ups
to Fortune 500 companies.
Liaised with clients, prepared client
documents for investors, built financial
models, discussed opportunities with
potential investors, and managed due
diligence on lean deal teams during
transaction execution.
Execution experience includes sale of
drug distribution company, potential partial
sale of multi-site specialty healthcare
services provider, and potential purchase
of outpatient rehabilitation company.
BCMS CORPORATE, New York, NY
Associate, M&A (2010 – 2011)
Analyst, M&A (2008 – 2010)
Worked on sell-side M&A transactions for
middle market private companies across a
range of industries, with experience in
healthcare, diversified industrials, oil and
gas, technology, and business services.
Co-led summer analyst and full-time analyst
orientation programs for the Los Angeles
office for two years.
24
Analyzed multimillion row claims data sets
to identify areas of performance improvement for a major academic medical center
attempting to eliminate $500m in expenses
over five years.
Managed and oversaw teams of junior
staff; prioritized tasks, set deadlines, and
supervised quality control process; trained
junior staff in technical skills as well as
provided them with industry knowledge.
LECG, Washington, DC and
Buenos Aires, Argentina
Associate (2010)
Research Analyst (2008 – 2010)
Assisted in preparation of expert report
regarding allegations of anticompetitive
behavior lodged against a large microprocessor manufacturer; research and
analysis resulted in a favorable verdict for
client.
Assessed European Union member
nations’ progress towards the unbundling
of electricity services; documented results
as part of an expert report; concluded
that unbundling is a necessary condition
for competition.
JAVIER LOPEZ-MOLINA
FARIDAH MANSOR
ELENA MAYER
jlopezmolina15@gsb.columbia.edu
fmansor15@gsb.columbia.edu
emayer15@gsb.columbia.edu
Management and Strategy
Social Enterprise and Strategy
Massachusetts Institute of Technology
MS, Biology, 2008
BS, Civil Engineering, 2006
Barnard College
New York, New York
BA, Economics, 2010
URS CORPORATION, New York, NY
Senior Project Engineer
2010 – 2013
Managed operations and program logistics
for $120m transportation construction
project.
NEW YORK CITY ECONOMIC
DEVELOPMENT CORPORATION,
New York, NY
Senior Project Manager
2010 – 2013
Led the implementation of three new
initiatives to connect low-income workers
to opportunities in growth sectors and
support entrepreneurship in low-income
neighborhoods.
Baltimore, Maryland
BA, Natural Sciences, 2003
STEM CENTRX, San Francisco, CA
Senior Research Associate
2011 – 2013
Developed cancer research protocol to
screen potential drug candidates in
patient-derived tumors resulting in data
that enabled two research partnerships,
licensing deals with major pharmaceutical
firms, and multiple patent filings.
Conducted experiments resulting in the
expansion of a collaboration with a
pharmaceutical firm and an overall revenue
increase of 20% for the collaboration.
Managed two teams that developed
pre-clinical drug candidates and filed two
US provisional patents.
WHITEHEAD INSTITUTE, Cambridge, MA
Intern
2011
Created marketing materials to promote a
breast cancer diagnostic.
Developed rationale for no-go decision
on patent prosecution, saving an estimated
$10k in filing fees and employee time.
MERCK & CO., Boston, MA
Program Team Member, Oncology
2009 – 2011
Designed and executed experiments that
enabled go decision for Phase II clinical
trial.
Led cross-functional team to identify value
engineering opportunities through in-depth
schedule and cost analyses.
Presented findings and recommended
action plan to client and third-party
stakeholders.
SCHLUMBERGER CANADA,
Newfoundland, Canada
Field Engineer
2007 – 2009
Acted as primary client liaison on offshore
drilling platform and led engineering
team responsible for over $2m worth of
equipment.
Developed complex drilling model with
real-time data and advised clients during
drilling operations.
ACCENTURE, Kuala Lumpur, Malaysia
Analyst
2007
Designed and implemented knowledge
management model with focus on processes
and organization.
Developed strategy and implementation
plan for a $1m vacant lot in outer Brooklyn,
directing a team of 12 across eight departments and coordinating with six city
agencies.
Managed two programs to facilitate the
expansion of foreign companies to NYC
(European tech startups, established
Chinese conglomerates, etc.).
LAKESIDE SCHOOL GLOBAL SERVICE
LEARNING PROGRAM, Seattle, WA
and Senegal
Senegal Trip Assistant Leader
2009 – 2010
Designed and oversaw community-based
service learning projects for US high
school students in rural Senegal.
Staffed trip from June-July 2010.
Collaborated with client end-users to
develop competency workshops and training
materials.
Managed laboratory functions: enabled
purchasing/maintenance of capital equipment, organized laboratory and tissue
culture work-space, and led DNA damage
group meetings.
2015 : Muckey – Parsonson
ERIN JOY MUCKEY
WASIB MUHAMMAD
ROSALYN NGUYEN
emuckey14@gsb.columbia.edu
wmuhammad15@london.columbia.edu
rnguyen15@gsb.columbia.edu
Strategy and Operations
Finance and Strategy
New York, New York
MD, 2015
McMaster University
Hamilton, Canada
MENG, Engineering Design, 2011
Indiana University
Bloomington, Indiana
BS, Biological Sciences, 2007
AB, Ecology and Evolutionary Biology, 2008
TRINITY PARTNERS, Waltham, MA
Focused on reimbursement strategy,
pipeline/portfolio optimization, corporate
strategy, promotional effectiveness, and
brand planning.
Experienced in oncology, cardiovascular,
pain, diabetes, rheumatology, and specialty
markets such as multiple sclerosis and
orphan diseases as a member of multiple
project teams.
Created detailed forecast models and
disease area landscapes, conducted
market research with major stakeholders
(payers, physicians, and key opinion leaders),
and performed detailed data analysis.
VANDERBILT UNIVERSITY INSTITUTE
OF IMAGING SCIENCE, Nashville, TN
Research Assistant
2007
Investigated the plausibility of using
non-invasive methods rather than biopsies
to assess fibrosis of the liver working
alongside graduate and medical students.
Analyzed the quantification of collagen
type I in mice livers at different stages of
fibrosis and its correlation with ultrasound
imaging, histopathology, MRI, and biomechanical testing.
26
Ryerson University
Toronto, Canada
BENG, Electrical and Computer Engineering,
2005
COLUMBIA TECHNOLOGY VENTURES,
New York, NY
Technology Ventures Fellow
2013
Assess commercial viability of scientific
inventions; construct fund and portfolio
company operating models supporting
pending capital raise.
ROCKWELL AUTOMATION, Singapore
Regional Program Manager (2013)
Project Manager (2012 – 2013)
Ran the Project Management Office within
a $4b division of Rockwell’s Engineered-toOrder businesses in APAC region; redefined the processes for project initiation,
risk mitigation, and embedded concept of
success metrics and gating mechanisms;
designed structure for in-house PMO.
ROCKWELL AUTOMATION, Milwaukee, MI
Business Process Consultant
2010 – 2011
Articulated end state vision for order
management system for a $4b business
unit; coordinated efforts with multiple
stakeholders to re-engineer business and
IT processes; directed onshore and offshore project teams of up to 8 consultants
on product lifecycle management
engagements.
ROCKWELL AUTOMATION, Cambridge,
Canada
Project Engineer (2008 – 2010)
Design Engineer (2006 – 2008)
Led and managed cross-functional,
international project teams to design and
implement product improvements for
automation and control systems.
MEMORIAL SLOAN-KETTERING
CANCER CENTER, New York, NY
Alliance Research Program Coordinator,
Department of Medicine
2009 – 2013
Piloted use of 30 novel therapies across
nine cancer subtypes in Phase II – III
clinical trials endorsed by NCI.
Notable collaborators: Pfizer, Genentech/
Roche, GSK, Merck & Co., Millennium
Pharmaceuticals, Amgen, and Celgene.
Ensured appropriate medical execution,
timely trial completion, adherence to
budgets, and compliance with quality
metrics.
Developed operational strategies and
organizational goals as member of senior
staff.
Hired and mentored cross-functional
research associates to staff team of six;
trained new hires (15 per month) for the
clinical trials office.
UNIVERSITY OF CHICAGO MEDICINE,
Chicago, IL
Regulatory Affairs and Compliance Manager,
Department of Medicine
2008 – 2009
Completed regulatory filings and developed patient consent forms for the Cancer
and Leukemia Group B research program
(comprised of 120 Phase II – III clinical
trials).
Advised physician staff on compliance
matters related to Title 21 of the FDA
Code of Federal Regulations and Office
for Human Research Protections.
Developed standard operating procedures
to align patient care goals, patient safety,
and stakeholder objectives.
SCOTT NISBET
SCOTT NITZ
MARK PARSONSON
snisbet15@gsb.columbia.edu
snitz15@gsb.columbia.edu
mparsonson15@gsb.columbia.edu
Management and Entrepreneurship
Marketing and Strategy
Finance
University of Michigan
Ann Arbor, Michigan
BS, Biochemistry, 2007
Boston College
Chestnut Hill, Massachusetts
BS, Management, 2007
London School of Economics
and Political Science
London, United Kingdom
BS, Economics, 2003
FLETCHER SPAGHT, INC., Boston, MA
Senior Analyst
2011 – 2013
Drove consulting engagements in medical
technology, diagnostics, life science tools,
pricing, market research, and more.
PIMCO, New York, NY
Associate
2011 – 2013
Delivered investment solutions to 15
corporate defined benefit clients totaling
$12b+ in AUM.
Led due diligence for investment in
sequencing reagent startup for associated
venture capital firm.
THE BROAD INSTITUTE, Cambridge, MA
Coordinator, Process Development
2007 – 2011
Managed quality control team in next
generation sequencing group.
Led process improvement initiatives in
bench chemistry, workflow, and IT support
systems.
Presented strategy updates, performance
attribution, and quantitative portfolio
analysis to CIOs, Treasurers, and corporate
investment committee members.
Identified and pursued cross-selling
opportunities for select clients across
PIMCO’s full spectrum of product
offerings.
FTI CONSULTING, INC., New York, NY
Senior Consultant
2007 – 2011
Developed integrated financial models
and performed ad-hoc financial analyses
including derivatives valuation, due
diligence, sensitivity analyses, and business
plan reviews for clients.
Advised on both creditor and debtor-side
clients, most notably Lehman Brothers
Holdings, Inc., ResCap (subsidiary of Ally
Financial, Inc.), and CIT Group, Inc.
Participated as lead in company’s on-campus
recruiting program for undergraduate
hires from Boston College.
LIONGATE CAPITAL MANAGEMENT,
London, United Kingdom
Executive Director
2009 – 2013
Led team that oversaw client investment
research across the firm’s global activities.
Managed strategic business and product
development, leading firm into new market
segments.
Secured and managed client investment
relationships with assets in excess of
$500m.
SEI INVESTMENTS,
Johannesburg, South Africa; London,
United Kingdom; Philadelphia, PA
Senior Client Investment Strategist
2007 – 2009
Executed redesign and repositioning of
firm’s investment offering within the
South African market, leading to first new
business wins for several years.
Developed valuation modeling of local
portfolios to extend SEI’s advisory services
to encompass total client portfolios.
Client Investment Strategist
2005 – 2007
Developed LDI-investment solutions to
expand target market by engaging corporate CFO’s in pension plan discussions.
Researched, implemented, and marketed
investment portfolios for roll-out of
firm’s flagship private wealth management
platform offering in EMEA.
Investment Analyst
2003 – 2005
Managed multi-billion dollar FX futures
trading program.
Led project to implement new fund
accounting platform, resulting in significant
operational cost reductions.
2015 : Perl – Sachs
ARI PERL
RITU RAJAN
BRAD REISMAN
aperl15@gsb.columbia.edu
rrajan15@gsb.columbia.edu
breisman15@gsb.columbia.edu
NYU School of Medicine
New York, New York
MD, 2013
Baltimore, Maryland
MS, Biotechnology, 2012
University of Michigan
Ann Arbor, Michigan
BA, Economics, 2009
Yeshiva University
New York, New York
BA, Economics, 2007
Rice University
Houston, Texas
BA, Biochemistry, 2009
AMNIOCHOR, Middletown, NJ
Associate
2011 – 2013
Worked with management team to create
comprehensive business plan, detailing
start-up’s strategy within stem cell banking
space.
FRANKEL GROUP, Cambridge, MA
Associate
2013
Supported nine diverse projects over
seven-month period, working with top
mid- to large-sized pharmaceutical, biotech,
and medical device companies.
Helped develop and patent proprietary
medical device to harvest and cryofreeze
company’s unique stem cells from
placenta.
Performed qualitative and quantitative
analyses to inform client decisions about
new product entry, business model
optimization, brand positioning, market
expansion, and M&A/financing activities.
Collaborated with CEO in efforts to raise
$2m A round; led discussion on market
opportunity and life sciences impact.
CREDIT SUISSE, New York, NY
Analyst, Strategy Group
Alternative Investments Department
2007 – 2009
Worked directly with executive management to conduct due diligence on new
business opportunities, strategic initiatives,
and M&A across various industries.
Spearheaded creation of SharePoint
database to aggregate and streamline
evaluation process; rolled-out across entire
asset management department.
Composed weekly Market Intelligence
Report, highlighting industry events, and
associated strategy analysis for department.
Mentored department’s summer interns
and supervised their collective research
project work.
28
Spearheaded primary and secondary
research across key industry stakeholders
(payers, providers), therapeutic areas
(oncology, ophthalmology, rheumatology,
infectious disease), and geographic
markets (US, France, China, Russia).
REATA PHARMACEUTICALS, Dallas, TX
Senior Manager (2012)
Manager (2010 – 2012)
Business Analyst (2009 – 2010)
Worked with VP of strategy (operating
COO) to provide leadership to key business
units; focused on building organizational
capabilities and supporting launch of new
product with breakthrough potential.
Led five-person team of internal and external
consultants, along with cross-functional
design teams, to create and implement
business processes for growing commercial
and R&D organizations.
Managed $272m business alliance with
leading Japan-based pharmaceutical
company; provided strategic, analytical, and
operational input for $800m partnership
with Abbott Labs (AbbVie).
Consultant
2010 – 2013
Conducted financial and market analyses
for several Fortune 40 pharmaceutical
clients, including brand value in different
stages of the post-patent expiry environment
and brand profitability compared to generic
competitor products.
Led development of reporting methodologies and tools for several Fortune 40
healthcare clients and created formal
communications to inform C-suite level
leadership on the performance of
critical programs.
Researched and evaluated 25 healthcare
IT solutions providers and recommended
vendor combinations and partnership
options to best support client strategic
objectives.
LIZA REYNOLDS
JENNIFER RHODES
STEVEN SACHS
lreynolds15@gsb.columbia.edu
jrhodes15@gsb.columbia.edu
ssachs15@gsb.columbia.edu
Consulting and Operations
Middlebury College
Middlebury, Vermont
BA, Psychology, 2009
BA, Cognitive Science and Communication,
2007
Cornell University
Ithaca, New York
BS, Biological Sciences, Biology & Society,
Finance, 2009
TOWERS WATSON, Chicago, IL
Consultant
2010 – 2013
Managed Talent Strategy development,
program design, and implementation to
align with business strategy for a global
pharmaceutical.
PWC, New York, NY
Manager (2013)
Associate (2009 – 2011)
Conducted 20+ M&A and strategy
engagements focusing on the healthcare
industries with experience in insurance,
consumer products, and technology.
CENTER FOR GLOBAL DEVELOPMENT,
Washington, DC
Europe Program Associate
2012 – 2013
Led project examining Europe’s commitment to economic development in poor
countries; analyzed data, drafted reports,
liaised with external experts and policymakers.
Conceptualized and implemented strategy
for Europe Program’s outreach, fundraising,
publications, and events to showcase
research and maximize impact.
Authored three research papers, one of
which was also published in the Journal of
International Development.
Special Assistant to the Director for Europe
2011 – 2012
Advised on opening of London office;
established Europe Program and launched
four policy initiatives.
Oversaw all London start-up operations,
produced and tracked $2m budget, and
managed personnel and recruitment.
Secured nearly $1m in additional funding in
first year from US and European sources.
GMMB, Washington, DC
Assistant Account Executive
2010 – 2011
Developed and implemented integrated
communications, advocacy and publicawareness campaigns focusing on public
health issues.
Oversaw messaging, media outreach, and
partnership development for healthcare
practitioner associations, the CDC, and an
international reproductive health coalition.
Led Change Management for transformation of procurement function in a financial
service institution, while building client
change management function.
Developed and delivered creative
communications to ensure employee and
management understanding of health
benefits, including implications of healthcare reform.
Defined intellectual capital for Talent
Management, Performance Management,
Culture Transformation and HR
Effectiveness in M&A.
TOWERS PERRIN, Philadelphia, PA
Associate (2007 – 2008)
Audited and redesigned Performance
Management programs in nonprofit,
hospital system, utility and insurance
organizations.
Created training program of eLearning
modules to increase employee ownership
and use of health and wellness benefits.
Supported Project Management Office
for M&A, HR Transformation and Health &
Wellness campaigns in health insurance,
utility and financial services industries.
Advised clients on growth strategy,
innovation, market entry, and business
planning.
Developed strategy and implementation
plan for statewide physician group to
enter into shared savings/ACO arrangements.
Advised payer on the acquisition of four
multi-specialty physician groups through
planning, diligence, deal execution, and
integration.
Facilitated healthcare market strategy
development for global telecommunications
company.
Developed international expansion plan
for leading US diabetes clinical care and
research organization.
D.E. SHAW & CO, New York, NY
Finance & Operations Summer Intern
2008
Wrote department Business Continuity
Plan after interviewing executives and
surveying 40 staff.
Investigated trade breaks and conducted
security valuation.
WYETH PHARMACEUTICALS,
Pearl River, NY
Summer Intern
2007 – 2008
Generated 60-page report for vaccine
formulation risk reduction to minimize
product / economic loss.
Designed biological assay to test efficacy
of vaccine candidates.
2015 : Sarelakos – Spiewak
CHRISTINA SARELAKOS
SAGAR SHAH
ZJ Shao
csarelakos15@gsb.columbia.edu
sshah15@gsb.columbia.edu
zshao15@gsb.columbia.edu
Entrepreneurship
Private Equity
Vanderbilt University
Nashville, Tennessee
BA, Chemistry, 2009
BS, Finance and Management, 2010
BS, Electrical Engineering, 2010
University of International Relations
Beijing, China
BA, International Economics and Trade, 2007
AMERICAN INTERNATIONAL GROUP,
New York, NY
Senior Financial Analyst
2012 – 2013
Joined the CFO’s office to help build the
Corporate Financial Planning & Analysis
(CFP&A) department from the ground-up;
created systems, processes, financial
models, and analytical reports.
Owner of 2013 budget; acted as main
point-of-contact between executive
team and each business area; collaborated
to conceptualize strategies that would
support firmwide goals ($4-$5b increase
in operating income, 10% reduction in
GOE, etc.).
Main lead for 2013 CCAR stress test;
worked across product areas to forecast
baseline, adverse, and severely averse
scenarios for income statement and
balance sheet.
GOLDMAN SACHS, Tokyo, Japan
Analyst
2009 – 2012
Worked in internal consulting group called
Operational Risk Management & Analysis
(ORMA), which collaborates with COOs to
identify risk exposure and implement operational changes aimed at mitigating potential areas of threat.
Created the Risk Register, a tool used to
quantify operational risk for entire country
offices; implemented cross-regional
metric report used to provide governance
committees with insight into emerging
market risk.
CORNERSTONE RESEACH INC.,
New York, NY
Senior Analyst
2010 – 2013
Led teams of three to ten analysts in
conducting financial and statistical analysis
in complex business litigation issues.
Interacted with expert economists and
clients to define scope of analyses, manage
expectations, and present results.
Enabled client to enforce $1.1b in derivatives
claims against a large bank that collapsed
during the financial crisis by developing a
valuation model to justify the claim.
Enhanced firm’s ability to add value to
clients in mortgage-backed security litigation
by pioneering the use of a relevant database and advanced regression analysis
templates.
Managed team of six to train 20 analysts
in economic concepts and technical tools;
selected for role by senior management
from pool of 13 candidates.
FIX IT!, New York, NY
Co-Founder
2010
Launched venture based on smart phone
and web-application technology to improve
efficiency of facilities maintenance
organizations.
Negotiated with an angel investor for seed
capital, generated buy-in from a board of
senior engineers and advisors.
Represented ORMA during inspections
with Japanese regulators (FSA, BOJ,
SESC); discussed Goldman Sachs risk
management in Japanese.
30
CHINA INVESTMENT CORPORATION,
Beijing, China
Summer Associate
2013
Researched and analyzed investments
across global markets and provided
recommen-dations to portfolio manager.
Represented CIC to actively participate
in key investor conferences, road show
presentations, and management meetings.
APAX PARTNERS, Shanghai, China
Associate
2011 – 2013
Sourced and assessed investment opportunities in retail/consumer and healthcare
sector; performed commercial/financial
analysis and designed transaction structure;
presented and discussed private equity
deals to global investment committees.
Closed a $250m buyout transaction in
the largest buffet restaurant operator in
China; led management discussion and
expert interview, conducted sector analysis,
designed customer survey, performed
financial and commercial due diligence.
MERRILL LYNCH, Shanghai, China
Analyst
2007 – 2009
Conducted a $240m leveraged buyout
investment evaluation in a meat processing
company; performed industry research,
financial analysis and commercial due
diligence; worked directly with management
to forecast earnings, built valuation model,
and coordinated the full due diligence
process.
GUNJAN SHESH
Robert Song
MONIKA SPIEWAK
gshesh15@gsb.columbia.edu
rsong14@gsb.columbia.edu
mspiewak15@gsb.columbia.edu
Consulting and Marketing
Operations and Entrepreneurship
Finance and Operations
MS, Bioengineering, 2010
New York, New York
MD, 2015
New York University
New York, New York
BS, Finance and Accounting, 2009
United States Military Academy
West Point, New York
BS, Electrical Engineering, 2003
New York, NY
Fixed Income Research Associate (2011 – 2013)
Research Analyst (2009 – 2011)
Analyzed the financial performance and
credit quality of 68 sub-investment grade
corporations in the building materials,
business services, machinery, general
industrials, mining, and coal sectors
through the construction and maintenance
of financial models and discussions with
investors and traders.
BS, Bioengineering, 2010
STRATEGIC RESEARCH INSIGHTS,
Plainsboro, NJ
Senior Research Associate (2012 – 2013)
Research Associate (2010 – 2012)
Conducted quantitative market research
for pharmaceutical clients at several stages
of the brand cycle and provided strategic
recommendations based on analyses.
Enhanced an ad campaign for a diabetes
brand that resulted in brand growth from
$2.3b to $3.3b.
Conducted global conjoint study to identify
an optimal contraceptive delivery method
for $600m brand.
Managed several long-standing client
relationships that led to multiple new
business engagements.
COLUMBIA DEPARTMENT OF SURGERY,
New York, NY
Research Assistant
2009 – 2010
Conducted data analysis and collected
data from patient records to facilitate
improved care of patients with various
forms of heart disease.
Assisted the organ retrieval team in
procuring hearts and lungs destined for
transplant; coordinated transportation
and supplies, and collected lab specimens
during organ retrieval.
Guided and mentored six junior associates
throughout each project process and
supervised six external vendors during
data collection processes.
UNITED STATES ARMY, Fort Riley, KS
and Afghanistan
2006 – 2008
Appointed and mentored leadership of
a newly formed Afghan Border Police
Company securing the Afghan border with
Pakistan.
Constructed a database of marketing
metrics that reduced time for benchmarking
new brand performance from six hours
to 15 minutes, compiling six years of
longitudinal data.
Implemented operations planning, budgeting, maintenance, and training, to develop
the unit from a disorganized and untrained
group of individuals into a competent and
capable unit.
UNITED STATES ARMY, Hohenfels,
Germany and Afghanistan
Infantry Platoon Leader
2003 – 2006
Platoon leader of a 30 soldier infantry
platoon responsible for maneuvering,
training, and safety.
Educated clients through morning
meeting announcements, published reports,
one-on-one conversations, and teach-in
presentations about high yield bonds
issued by corporations to fund capital
projects and acquisitions, refinance debt,
and return cash to shareholders.
Published over 150 weekly reports and
five quarterly books highlighting relevant
issuer-specific and industry-wide events.
BANK OF AMERICA SECURITIES,
New York, NY
Summer Equity Research Analyst
2008
Examined 25 healthcare technology and
distribution stocks by monitoring financial
and industry news and interpreting the
impact of recent developments on all
companies under coverage.
Contributed macro-economic and company-focused data to the team’s initiation
report on the retail pharmacy sector.
Selected as one of three platoon leaders
out of 15 in the battalion to lead soldiers in
a deployment to Afghanistan providing
security during elections; rated as the top
platoon leader in the battalion.
2015 : Stucka – Wang
SABRINA STUCKA
ZAHRAH TAUFIQUE
KELLY THOMAS
sstucka15@gsb.columbia.edu
ztaufique14@gsb.columbia.edu
kthomas15@gsb.columbia.edu
Social Enterprise and Strategy
Northeastern University
Boston, Massachusetts
BS, Chemistry, 2010
New York, New York
MD, 2015
Villanova University
Villanova, Pennsylvania
BS, Biology, 2011
CUBIST PHARMACEUTICALS,
Lexington, MA
Research Associate II
2010 – 2013
Designed and synthesized analogues for
a variety of proprietary drug targets for
use in the acute care environment.
Columbia University
New York, New York
BA, Political Science, 2009
PHARMASTRAT, Parsippany, NJ
Consultant
2011 – 2013
Developed a new product offering which
allows clients to obtain rapid feedback
from payer or physician stakeholders prior
to the full launch of a market research
initiative.
Initiated the development and trained
colleagues on use of parallel methodology
to increase the amount of drug candidates
produced at one time from one drug
candidate to 24 drug candidates.
Led a committee of 30 cross-functional
employees as chairperson on the
development of science demonstrations
and hands-on activities for 90 children,
organized and ordered all giveaway
items, and diligently communicated the
schedule for the largest and most
well-received Take Your Child to Work
Day to date.
MERCK & CO., Boston, MA
Medicinal Chemistry Co-op
2009
Developed and optimized an independent
six-month research project on the parallel
synthesis of ureas and carbamates for
use in pharmaceutically active compounds.
Published research findings in a major
organic chemistry journal and personally
presented research at the 239th annual
American Chemical Society national
conference in San Francisco, CA.
Developed chemical technology that has
been institutionalized at Merck for future
use to facilitate rapid development in
ongoing drug discovery programs.
32
MT. SINAI GAUCHER PROGRAM,
DEPARTMENT OF GENETICS,
New York, NY
Clinical Research Coordinator
2009 – 2010
Assisted with two clinical trials and directed
a treatment protocol addressing the 2009
Cerezyme shortage, including working with
the drug trial sponsor, Shire
Pharmaceuticals.
Partnered with Genzyme to coordinate
patient treatment and manage the upkeep
of the center’s contribution to the Gaucher
International Registry.
Coordinated the logistics for the treatment
of Gaucher patients receiving enzyme
replacement therapy.
SAH PROGRAM IN NEUROCRITICAL CARE,
NEWYORK–PRESBYTERIAN HOSPITAL/
COLUMBIA UNIVERSITY MEDICAL CENTER,
New York, NY
Research Analyst
2007 – 2012
Authored and submitted an abstract titled
“Quality of Life One Year after
Subarachnoid Hemorrhage: The Columbia
University SAH Outcomes Project,”
accepted at the 2012 Neurocritical Care
Conference in Denver, Colorado.
Created a Microsoft Access database
for an ongoing cerebral spinal fluid analysis
project.
Conducted follow-up interviews of patients
that had suffered from a subarachnoid
hemorrhage.
Tested market perceptions and value
messages with US and European payers to
inform development of future clinical trials
and value proposition of an orphan drug.
Led and managed a 30 person advisory
board meeting which included 16 urology
stakeholders to inform the prioritization
and investment decisions of six business
opportunity concepts.
Investigated pricing and product strategy
for a dermatologic product to build upon a
strategy for mitigating generic substitution,
increasing market share, and obtaining
optimal managed care coverage for the
product.
LEERINK SWANN, New York, NY
Summer Analyst
2010
Developed and presented a financial
model which analyzed US Physical
Therapy, Inc.’s leveraged buyout candidacy
to a group of senior bankers.
ALEX TUROK
Nathan Walcker
ZHENZE (ANGELO) WANG
aturok15@gsb.columbia.edu
nwalcker15@gsb.columbia.edu
zwang15@gsb.columbia.edu
Finance
Strategy and Finance
Cornell University
Ithaca, New York
BS, Applied Economics and Management,
2008
Columbia University
New York, New York
BA, Economics, 2009
Zhejiang University
Hangzhou, China
BA, English, 2010
BS, Business, 2010
ZS ASSOCIATES, Princeton, NJ
Consultant (2013)
Business Associate (2009 – 2010)
Specialized in sales and marketing strategy
for US pharmaceutical companies.
Studied over 15 therapeutic areas with
emphasis on HIV, Diabetes, Atypical
Antipsychotics, Pain, and Central Nervous
System products.
Managed multiple project teams in
quantitative physician market research
including: ATU, sales force effectiveness,
patient chart audit, and message testing
studies.
Redesigned the sales force territory
alignment and personnel placement for
four top 50 US pharmaceuticals
companies.
Moderated 15+ focus groups across all
functions of operations and synthesized
best practices into a Launch Planning
Guide, later used by sales and marketing
leadership to plan for five US product
launches.
Integrated qualitative and quantitative
research findings to help a Fortune 100
pharmaceutical company improve the
creative design, message and appearance
of a national advertising concept.
New York, NY
Global Capital Markets Senior Analyst,
2011 – 2013
Advised private and public healthcare
companies across verticals seeking to raise
equity and/or equity-linked capital.
Executed transactions for common stock
offerings, (un)registered block sales and
financings.
Led drafting of marketing materials for
equity financing documentation.
Analyzed Value-at-Risk (VAR) of global
block trade business and presented findings and recommendations to senior-level
firm executives.
Global Markets Analyst
2009 – 2011
Analyzed equity securities and made
stock recommendations based on in-house
Excel models and fundamental research.
Delivered firm resources to buy-side fund
managers and clients.
Authored daily capital markets note
detailing multiple trends, pricing metrics,
and performance.
L.E.K. CONSULTING, Shanghai, China
2010 – 2013
Designed and developed strategy for
pharmaceutical /medical technology/
healthcare service clients; topics covered
included sales, distribution, products,
and strategy.
Advised healthcare-related transactions
for leading corporate and private
equity clients, providing commercial due
diligence and financial forecasting.
MCKINSEY & COMPANY, Shanghai, China
Analyst Intern
2009
Extensive consumer data analysis
at McKinsey’s China Consumer Center,
covering 15k+ samples across
58 cities in China.
Leveraging SPSS and excel analytical
tolls including product funnel, key buying
factors, derived importance, and cross
tabulation.
Managed project deliverables for sales
strategy implementation; coordinated with
client contacts across Sales, Operations,
IT, HR, and Legal.
Presented final recommendations to the
CEO and Vice Presidents of a mid-size
pharmaceutical company.
2015 : Yang
JENNY YANG
jyang15@gsb.columbia.edu
BS, Economics and Nursing, 2007
BLACKROCK, San Francisco, CA
Senior Business Finance Associate
2012 – 2013
Modeled key strategic initiatives for
executive management by performing NPV
and operational expense analyses to
help identify opportunities in revenue
enhancement, cost reduction, and internal
processes improvement.
Crafted Board of Directors presentations
and monthly/quarterly forecasts to
ensure a timely and accurate depiction of
company financials.
CODEXIS, Redwood City, CA
Senior Financial Planning Analyst
2011 – 2012
Led the development of the 2012 strategic
financial plan that consisted of transforming a historically consolidated view of
corporate operations into a bottoms-up
departmental view enabling manager
accountability.
Collaborated with project managers on the
assessment of high revenue product cash
flow by tracking sales and conducting cost
benefit analysis.
JEFFERIES & COMPANY, San Francisco, CA
Healthcare Investment Banking Analyst
2009 – 2011
Analyzed and summarized performance
of capital markets and medical device
companies in support of weekly industry
reports to senior management.
Spearheaded the Annual Jefferies Life
Sciences Conference by leading a small
team to organize and execute more than
200 clients meetings with senior managers
across various healthcare platforms.
34
NOTES
NOTES
36
10th Annual Columbia Business School
Healthcare Conference
November 22, 2013
New York Marriott Marquis
Healthcare and Pharmaceutical Management Program
www.gsb.columbia.edu/healthcare
Healthcare Industry Association (HCIA)
www.gsb.columbia.edu/students/organizations/hcia

ReSUMe BOOK - Columbia Business School

Transcription

Similar documents

InBody720 Spec Sheet

OAK HALL LANE - Merritt Properties

BP Columbia ParCar Enlargement.indd

Do you have joint pain? It could be Rheumatoid Arthritis.

suMMer 2010 - Columbia Business School

scott phillips - scott michael phillips

CapnalOne" healthcare finance"

Fifth Annual Moving Forward Together Secondary Transition Fair

December 2010

about take command health